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 The purpose of this study was to determine the association of each of five 
cardiometabolic risk factors (diabetes, hypertension, elevated triglycerides, low high 
density lipoproteins, obesity), and MetS (three or more risk factors present) with the level 
of physical function 1) prior to surgery in patients with TKA/THA surgery and 2) 6 
weeks postsurgery in patients with TKA/THA surgery, controlling for age, sex, physical 
activity, and comorbidity.   
Patient physical function data were retrospectively extracted from a clinical 
orthopedic database between September of 2008 and November of 2010. Comorbidities 
were obtained by chart abstraction. Patients were ≥40 years old with a primary total hip 
or knee arthroplasty. Relationships between MetS and its individual components, and 
physical function were completed using the Lower Extremity Function Scale (LEFS) and 
SF-36 physical component score (PCS).  Covariates were age, sex, comorbidities, and 
physical activity. 
Preoperatively, a total of 174 TKA and 112 THA candidates were included.  For 
TKA candidates, mean LEFS scores were significantly (p<0.001) lower for patients with 
MetS (30.0, SD 14.2) than without MetS (39.9, SD 16.0).  In TKA cohort, MetS 
remained significantly associated with reduced lower-extremity physical function; 
additionally, female sex, chronic back pain and insomnia significantly reduced 
preoperative lower-extremity physical function, in the adjusted analysis.  For THA 
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 candidates, adjusted analysis found MetS and being female were significantly (p<0.05) 
associated with worse lower-extremity physical function.   
Postoperatively, 170 and 111 patients with a total knee and total hip arthroplasty 
were included.  In the adjusted analysis: Diabetes, chronic back pain and presurgical 
physical function remained significantly associated with reduced postoperative lower-
extremity physical function.  For THA, being female, chronic back pain and presurgical 
physical function were significantly (p<0.05) associated with worse physical health.  
MetS was not significantly associated with postoperative physical function (PCS or 
LEFS) in the THA/TKA population. 
This study provides evidence that MetS, back pain, and insomnia are modifiable 
conditions that influence preoperative physical function while back pain, diabetes and 
preoperative physical function are modifiable conditions that influence postoperative 
physical function.  MetS was not associated with postoperative physical function in either 
the TKA or THA cohort. 
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This chapter is composed of two sections.  The first section is a brief overview of 
what is known about the postsurgical recovery of patients with total knee or total hip 
arthroplasty (TJR).  The second section is an introduction to the Health Outcomes in the 
Arthroplasty Population project, an overview of the development and implementation of 
patient outcomes into routine clinical practice. 
 
1.1  Review of the literature 
Osteoarthritis (OA) is the most frequently reported condition utilizing TJR for 
management of pain and disability.   There is generally a high success rate with TJR yet 
there is approximately 15% -30% of the TJR population that is not satisfied with their 
surgical outcome.  Clarification of the expected postoperative recovery and determining 
what factors are related to recovery pattern is required to better understand how TJR 
patient outcomes can be improved.  Many patient related factors have been investigated 
to predict TJR outcome.  Specifically, comorbidity is one patient factor that has been 
poorly measured and documented in the TJR population.  The high prevalence of 
comorbidity in the OA population may indeed impact the outcome after TJR as these 
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 comorbidities are not modified by the TJR surgical procedure and may contribute to the 
compromised TJR success rate. 
 
1.1.1 Osteoarthritis 
Osteoarthritis (OA) is highly prevalent,
1-2
 incurs substantial costs and functional 
challenges.  Most people live for many years with OA which gradually worsens.  The 
clinical symptoms are dominated by  pain and functional impairment that includes joint 
stiffness and dysfunction most commonly related to the joints of hip, knee, hand, foot and 
spine.
3
  This leads to impaired performance in the workplace; 25% of patients cannot 
perform their main activities of daily life, which often leads to social isolation and 
depression.
4-5
 More than 13% of Americans aged 55 to 64 years and more than 17% of 
Americans aged 65 to 74 years, have pain and functional limitations related to knee OA.
1
  
In addition to the direct costs incurred due to health care utilization in diagnosis and 
treatment of OA, indirect costs are incurred by both patients and their caregivers related 
to absence from loss of work days due to treatment, reduced effectiveness at work and 
losses attributable to the disease preventing persons from working at, or taking, better 




1.1.2 Total knee and hip arthroplasty 
 Management of end stage OA often results in a patient undergoing a total knee or 
total hip arthroplasty (TJR).  In 2006, 454,000 primary total knee and 232,000 total hip 
arthroplasty surgeries were performed.
7
  The estimated total hospital cost for joint 
replacements in 2004 was $30 billion.  When evaluating surgically related outcomes, TJR 
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is seen as an effective intervention, there is a low rate of mortality and few severe adverse 
outcomes associated with the surgery.
8-11
  Studies have shown that TJR’s improve 
patient’s health related quality of life(QoL), reduce pain and increase functional 
capacity.
12-16
  Yet, about 15-30% of patients report little or no improvement after surgery 
or are unsatisfied with the results.
17-22
  The number of TJR’s is predicted to increase such 
that by the year 2030 there will be over 3.5 million procedures completed per year.
7
  
Although TJR is one of the most clinically successful and cost-effective interventions in 
medicine
23-26
 due to the high the number of TJR procedures predicted to increase there 
could conceivably be a substantial proportion of the population who report little or no 
improvement.  Thus, understanding determinants of patient success or nonimprovement 
is essential.  
 
1.1.3 Recovery after total joint replacement 
The pattern of recovery after TJR is an important aspect of the rehabilitative 
phase after surgery which provides guidance to patients, caregivers and medical staff.  
Interpretation of the physical function pattern of recovery has been convoluted due to 
varying time points being evaluated (early, short and long) and multiple outcomes.  
 Postoperative functional ability has been evaluated with different outcomes such 
as quadriceps strength,
27




 and physical performance 
measures
30, 32
 thereby making comparisons difficult.  Recently, Kennedy et al. (2006) 
graphed physical function in the early phase of recovery (with 15 weeks after surgery) 
and showed that recovery was nonlinear with an accelerated rate of recovery occurring in 





     Similar results were seen in studies which with 1-2 year follow-
up time periods of recovery were graphed.
31, 34
 These studies provide an excellent 
visualization as to what recovery looks like in a controlled research setting.  Confirmation 
that the pattern of recovery is similar in the actual clinical setting, where patients are not 
recruited and methodologically scheduled for follow-up appointments, is yet to be 
determined.  To understand what is happening in the rehabilitation phase after TJR, we 
have completed preliminary analysis of  patterns of recovery within the usual physical 
therapy practice setting evaluating the pattern of recovery of those with total hip 
replacement (THR) that have functional outcome measurements for at least three physical 
therapy visits.   Using the minimally clinically important difference (MCID) as the 
measure of change, patient self-reported functional evaluation measures showed that 65% 
of the postoperative THR patients had achieved significant amount of improvement from 
their first appointment whereas 32% of the THR did not change and 3% were worse than 
their first appointment.  Further, preliminary examination of patient characteristics (age, 
gender, time from surgery and the number of visits) indicated that there may be a 
differences between changers and nonchangers.
35
  Mixed-model nonlinear graphing of 
this population resulted in a similar recovery pattern illustrated by Kennedy et al.(2006) 
although the patients in the actual clinical practice started with a lower functional 
outcome at initiation and had a lower functional outcome at discharge.
33
   Useful as a 
guideline, these recovery curves also show that the accuracy of the predicted recovery for 
an individual patient may be due to the various patient related factors that contribute to 
TJR recovery due to the large amount of variation seen in the rate of recovery.  The 
clinical data in this preliminary work have selection bias, as these patients are only those 
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who attend physical therapy; there is a gap in knowing how many people after surgery 
receive outpatient physical therapy and the pattern of recovery for all patients. 
 
1.1.4 Factors relating to recovery 
Determining what characteristics provide the best predictor of recovery is 
inconclusive.  Understanding what characteristics affect the patient’s recovery pattern 
and functional outcome would provide important information in the management of the 
postoperative TJR patient.   Patient related factors such as demographic variables (age, 
weight and sex), medical variables (diagnosis, comorbid conditions and ambulatory 
status), patient satisfaction, physical function and health related quality of life (QoL) have 
all been investigated with inconsistent results.  There is limited consensus on what factors 
affect outcome.  Variables that have achieved some consensus on postsurgical outcome 
are sex; preoperative physical function and health status; and whether the patient 
undergoes a unilateral or bilateral procedure.
13, 27, 29-30, 36-43
  
 
1.1.5 Importance of comorbidities 
Comorbidity is one patient characteristic that has not been well studied in the TJR 
population.  Comorbidity is defined as the co-occurrence of two or more diseases in the 
same individual.
44
  Comorbidities have shown to increase the risk of major health-related 
outcomes (disability or mortality), higher health care utilization and expenditures.
45
  OA 
is one of the diseases with the highest rate of comorbidity
46-48
 and patients with OA have 
a significantly higher risk of developing comorbidity than non-OA patients.
49-50
  
Generally, there is no increased risk of mortality related to OA but there is moderate 
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evidence of increased cause-specific mortality among persons with OA compared with 
the general population from cardiovascular and gastrointestinal disorders.  Risk factors 
for mortality in persons with OA included an increased burden of osteoarthritis, advanced 
age and presence of comorbid conditions.
51
  
As previously established, people with OA have increased disability.  Similarly, 
people with comorbidity have increased disability
52-57
  Understanding how comorbidities 
may influence TJR functional outcomes is important to the recovery process and may 
help to explain the faction of people not satisfied or report limited change after the pain 
from OA is removed with joint replacement.  
 
1.1.6 Measuring comorbidity  
In the TJR population measurement of comorbidity has mainly been used to 
control for confounding, estimating the risk of death, complications and costs.  Rarely has 
comorbidity been used as a predictor of functional outcome.  Measures of comorbidity 
can be as simple as a count of the number of comorbid diseases present 
46, 58
 or the 
measure can be a more comprehensive index that accounts for disease severity.  
Comorbidity measurement approaches used in the TJR literature are varied and 
inconsistent.  Measures of comorbidity have not been developed for an OA or TJR 
population and often the population that was used in the development is not comparable 
to the TJR population or does not include conditions that are important to the TJR 
population.   For example, the Charlson Comorbidity Index (CCI) was developed to 
measure the relative mortality risk for people aged more than 65.
59
  The CCI is composed 
of 22 medical conditions each assigned with a weight scale ranging from 1 to 6 
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depending on the risk of dying. The final CCI score is the sum of the weights assigned to 
22 predetermined clinical conditions, a higher score correlates with greater burden of 
comorbidities and can be used to predict one year mortality.
59
 Some studies which have 
counted the number of comorbidities and then establish cut points that do not support the 
prevalence of comorbidity in the OA population nor are standardized to allow for 
comparison across studies cut points.  For example, one study established cut off values 
of comorbidity as ‘none’ and equal to or greater than 1.  The expected prevalence of 
comorbidity is underrepresented compared to what is noted in the OA population.  
Verification of the prevalent comorbidities in the TJR population and valid measures of 
comorbidity are needed in the TJR population.
29
  In addition, often only a summed value 
was provided for a dichotomized variable without any indication of which conditions 
were included in the sum or the number of conditions reviewed.  There has been only one 
study which has specifically studied the impact of specific comorbidities on QoL.
60
 This 
study was a cross-sectional survey of 293 veteran men who had undergone a primary 
TKA.  Health status information was collected 2-3 years after surgery using the Short 
Form-36 for veterans (SF-36 V) while comorbidity information was acquired from the 
Veterans Affairs database probably at the time of surgery.  Multivariate linear regression 
was used to assess associations between individual component scores of the Short Form-
36 for veterans (SF-36 V) and the two summary scores (physical component (PCS) and 
mental component (MCS)) and five comorbidities (chronic obstructive pulmonary 
disease (COPD)/asthma, diabetes, depression, hypertension and heart disease).  Results 
indicate that medical and psychiatric comorbidity are negatively associated with 
mental/emotional QoL, individual comorbidities have different affects on QoL and that a 
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greater number of conditions negatively impacts both physical and mental/emotional 
QoL.   
Four areas have been highlighted establishing comorbidity as an area requiring 
further research in the TJR population, summarized as follows:  1) there is a high 
prevalence of comorbidity established in OA population but limited studies have 
investigated comorbidity for those undergoing TJR surgery,  2) there are few 
standardized conditions and comorbidity indexes used in the measurement of comorbidity 
in the TJR population, 3) comorbidity is often used as a means for adjusting for common 
diseases rather than being used to provide consideration for the impact the specific 
comorbidity may have on TJR functional outcome and 4) there has only been one study 
that has specifically investigated the association of comorbidity and functional outcome 
although this study has some methodological problems.   
 
1.1.7 Cardiometabolic risk factors  
Cardiometabolic risk (CMR) is defined by the American Heart Association as major 
risk factors (RF) that significantly increase the risk of heart and blood vessel disease and 
are classified as modifiable (diabetes, obesity, hypertension, inflammation and 
anticoagulation, abnormal lipid metabolism, physical inactivity, smoking) and non-
modifiable risk factors (age, gender, race, ethnicity and family history).
61
  The 
relationship of OA and cardiovascular disease (CVD) is twofold.  First, the most common 
comorbidity for people with OA is CVD.
49
  Second, recent research suggests the etiology 
between OA and CVD are as associated disease pathways with differing outcomes 
mainly as a result from the inflammation process within the body.
62
  The expected 
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outcome after TJR is to have relief of pain and regain functional ability.  If these CMR 
factors are prevalent in the TJR population these CMR factors may be contributing to the 
dissatisfaction or lack of improvement in the TJR population even after the OA related 
impairments and disabilities have been remedied with TJR. Limited studies have 
specifically investigated these CMR factors and their affect on TJR outcome and are 
briefly reviewed here.  
Diabetes and obesity are the most researched of the CMR risk factors in the TJR 
population and have mixed findings reported.  Some studies have shown that those with 
diabetes (DM) are more likely to be discharged to a rehabilitation center rather than going 
directly home and have slower rates of progression after surgery but at one year after 
surgery patients with DM appear have the same level of function as those without DM.  
When functional outcomes are evaluated 3-8 years after TKA surgery patients with 
diabetes are associated with both worse functional and better knee function than those 
without DM.
63-64
  Differences between those with and without DM are noted when 
outcomes are evaluated during the hospital stay which have shown increased odds of 
stroke, pneumonia and transfusion and often have more complications in those with DM 
than those without DM resulting in increased utilization of resources and cost.
65-67
    
The effect of obesity on recovery is inconclusive.  Studies have shown TJR patients 
who are obese  have increased complications but the effect on functional outcome is 
unknown,
67-69
 while other studies show that obesity is negatively correlated with 
functional score
70
 and yet other studies are unclear or show no effect for short-term and 
long-term outcomes.
13, 38-39, 71-72
 The perplexity with obesity may be the other conditions 
that are often associated with obesity such as hypertension (HTN), lipid metabolism and 
10 
 
inflammation.   
Of the remaining modifiable risk factors, one study has investigated hypertension 
(HTN)
67
 and one study investigated physical activity
73
 in the TJR population. There are 
no reports of the effect of lipid metabolism and inflammation on the outcome of TJR.  
HTN has been shown to be a major risk factor for complications after TJR, an 
independent predictor of postoperative complications and nonhomebound discharge but 
has not specifically been assessed with functional outcome.
67
  
Reports on the amount of physical activity (PA), a critical component in the 
rehabilitation phase after TJR and a modifiable risk factor, are limited in TJR literature.  
Wegenmaker et al.(2008) found that THA patients in Holland are at least as physically 
active as a normative population after THA.  It is unknown whether similar findings 
would apply to a USA population.
73
 
The clustering of CMR factors (central adiposity, elevated fasting glucose, 
hypertension and dyslipidemia defined by high serum triglycerides and low high-density 
lipoprotein cholesterol) is referred to as metabolic syndrome.  Metabolic syndrome, is 
increasing in prevalence and appears to be related to the increased risk of developing 
CVD and diabetes yet the contribution of metabolic syndrome towards cardiovascular 
risk has been debated over the last few years.
74
   There is agreement regarding the 
important independent contribution each CMR risk factor takes in cardiovascular health.  
A lack of consensus remains regarding the effect of the sum of these individual risk 
factors and their added contribution towards defining cardiovascular risk.  Many of the 
traditional cardiovascular risk factors (age, sex, cigarette smoking and low-density 
lipoprotein cholesterol levels) established in large part by the Framingham Heart Study 
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(Framingham Risk Index),   are not included in the metabolic syndrome definition and 
thus metabolic syndrome cannot be used to predict absolute risk.   Quantification of 
metabolic syndrome has led to different definitions of metabolic syndrome and recently 
has led to a Joint Scientific Statement summarizing the accepted present definition of 
metabolic syndrome.
74-76
  Recently, there have been findings on the effect of specific 




  One 
study by Gandhi et al. (2007) assessed the prevalence and implications of metabolic 
syndrome in the TJR population.
77
  Of the 1231 patients who underwent primary hip and 
knee surgery, 24.4% (n=300) were found to have metabolic syndrome.  There is some 
indication that the clustering CMR factors may contribute to postoperative CV 
complications.  The contribution of CMR factors to other TJR is yet to be determined. 
 
1.1.8 Conclusion 
In summary, the population with OA is aging and they are undergoing TJR surgery 
with an unknown number of comorbidities.   Presently, 15-30% of the TJR population is 
not satisfied with their outcome postsurgery.  In the next 30 years, an exponential 
increase in TJR is predicted; therefore it is important to identify those that are at risk for 
poor outcomes to maximize the resources available and to benchmark clinical practice.  I 
propose that by understanding the recovery pattern in clinical setting, quantifying the 
comorbidity within the TJR population and specifically analyzing how these 
comorbidities impact on the recovery process we may estimate another major contributor 




1.2  Health outcomes in the arthroplasty population 
An integral aspect of my PhD experience has been the development of the Health 
Outcomes in the Arthroplasty Population (HOAP) program.  The HOAP program was 
initiated as a combined venture with the Department of Physical Therapy, the University 
Orthopedic Center (UOC) Physical Therapy department, UOC Total Joint Team and 
myself, with the mission to improve patient outcomes using evidence-based practice.  
This was part of a practice-wide effort to improve patient outcomes after total joint 
replacement.   
To be able to improve patient outcomes we needed to know what the patient 
outcomes were in this clinical setting. Important key points for the development and 
implementation of  HOAP were to integrate into the existing clinical practice routine 
without disruption of patient flow, or extra patient burden (i.e., extra time or paperwork), 
to use existing personal and integrate physical therapy with the total joint program team 
to facilitate cross professional communication. 
The development and implementation of the HOAP program contained five distinct 
phases.  In the first phase, existing clinical systems and processes were evaluated.  
Decisions were made to complement, modify and enhance the present system.  For 
example, the data collection process for physician reported measures was changed from 
retrospective chart audit to residents and fellows collecting patient information directly 
on standardized forms at the time of service. 
Understanding patient outcomes from a patients’ perspective was set as a high 
priority.  In the second phase (February-September 2008), decisions were made regarding 
the type of self-report measures that would be implemented to understand the patients’ 
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perspective regarding their clinical outcomes.  Based on these decisions, a booklet of 
questionnaires was developed and pilot tested.   
The third phase (November 2008-February 2009) was the development and 
implementation of Joint Camp, a preoperative educational component provided to 
patients on a weekly basis.  The content was developed by physical therapists and the 
antithrombosis group with input from HOAP team.  Also at this time, we initiated 
performance measures (6-minute walk test and timed stairs) for those attending Joint 
Camp so that physical performance patient outcomes could be tracked. 
The fourth (June 2009-present) and fifth (Dec 2009) phases involved the development 
and implementation of the process to gather physical performance measures 
postoperatively at 6 weeks and 6 months, respectively. 
All data gathered in the HOAP program were collected in an ACCESS database that I 
serve as the data administrator.  The primary data source for this project was based on 
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OBSERVATIONAL STUDY OR RANDOMIZED CLINICAL TRIALS: 
CHALLENGES IN MEASURING CHANGE 
 
3.1  Abstract 
Evaluating whether a person has changed with treatment is a fundamental aspect 
of physical therapy practice and research.   Historically, randomized clinical trials have 
been the primary source of evidence to evaluate treatment effectiveness.  More recently, a 
complementary method, observational study designs, has become more prevalent in 
physical therapy to evaluate the effectiveness of interventions due to the availability and 
introduction of registry and electronic database information.  Understanding the 
assumptions, limitations and specific analysis strategies unique to data gathered using 
observational study designs is necessary to provide accurate assessments of the 
effectiveness of physical therapy interventions.  The purpose of this paper is to review the 
traditional techniques used to analyze the measurement of change due to physical therapy 
interventions in randomized trials and to discuss alternative analysis methods developed 
for use in observational studies.   Traditional data analysis techniques may not be suitable 
for data used from registries and databases.  New methods in design and analysis, such as 
hierarchical linear modeling and propensity score matching, are advances that can 
provide more accurate methods to report and evaluate change in observational studies.  
36 
 
3.2  Introduction 
The availability and use of electronic databases are increasing in physical 
therapy.
4, 7
  Interpreting the data available from databases requires considerations and 
techniques that may be unfamiliar in physical therapy.  Therefore, there is a need for 
attention to be given to the methodological issues involved. To provide accurate evidence 
of the effectiveness of physical therapy, it is essential to accurately match the study 
design to the subsequent analysis.  Each study design presents with unique sets of 
assumptions, limitations and specific analysis strategies most appropriate for handling 
these considerations.  Inappropriate use of analysis techniques that are not matched to the 
study design from which data are collected can lead to biased conclusions that may 
erroneously support ineffective physical therapy techniques or deny potentially effective 
techniques.   
  The goal of any study design is to maximize the degree of internal validity (the 
best approximation of the truth) and external validity (ability to generalize to the affected 
population) to answer the study question.  Detailed definitions of statistical terms are 
presented in Table 3.1.  Studies with a high degree of internal validity may be able to 
evaluate a treatment effect in a controlled research setting, but this high degree of control 
may not be suitable for extrapolating to patients in the clinical practice setting.
6
  The 
randomized clinical trial (RCT) is the classic study design for maximizing internal 
validity because this design is conducted within a clinical setting that is controlled, to a 
certain extent, by enrolling patients who meet prespecified criteria and provide informed 
consent.  Controlled settings and more homogeneous patient samples in RCTs may not 
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Table 3.1 Statistical terms  
Statistical Term Definition  
Randomized control trial participants are randomly allocated to an intervention(s) in a 
controlled setting prior to the intervention being evaluated 
Observational study 
design 
observation or measurement of outcomes without impacting 
the outcome using an intervention 
Efficacy the ability of an intervention to produce the desired beneficial 
effect under ideal circumstances 
Effectiveness the degree to which action(s) achieves the intended health 
result under normal or usual circumstances 
Internal validity the degree which the experimental treatment makes a 
difference in the specific setting 
External validity the degree the results are generalizable to the affected 
population 
Confounding a situation in which the estimated intervention effect is biased 
because of some difference between the comparison groups 
apart from the planned interventions such as baseline 
characteristics, prognostic factors, or concomitant 
interventions. For a factor to be a confounder, it must differ 
between the comparison groups and predict the outcome of 
interest 
Covariates a variable that is possibly predictive of the outcome under 
study 
Regression to the mean a variable is extreme on its first measurement, it will tend to 
be closer to the average on a second measurement 
Selection bias a systematic error in creating intervention groups, causing 
them to differ with respect to prognosis. The groups differ in 
measured or unmeasured baseline characteristics because of 
the way in which participants were selected for the study or 
assigned to their study groups 
Treatment effect a measure of the difference in outcome between intervention 
groups 
Directional bias results of a study systematically deviate in one direction from 




 reflect “real-world” clinical circumstances, limiting the external validity of RCT results.  
A key distinguishing feature of RCTs is random (i.e., chance) assignment of participants 
to treatment which optimally balances treatment groups for all possible differences that 
could impact outcomes other than the treatment itself.
34
  In contrast, observational study 
designs often involve the collection of data within clinical settings that are more typical 
of routine practice and are more inclusive of all patients within those settings.  
Observational designs therefore typically have high external validity and are more 
generalizable to the general population. Observational studies do not use random 
processes to assign patients to treatment groups, creating the possibility that groups of 
patients receiving different treatments also differ on other important variables (e.g., 
duration of symptoms, age, etc.) that could partially, or wholly, explain any differences in 
outcomes between treatment groups.  In this way, observational studies may lack 
sufficient internal validity to interpret their results as conclusive. Although vastly 
different in their execution both the RCT and observational study design can be used to 
evaluate the effectiveness of different treatments.
25
    
Recently, national initiatives to routinely gather outcomes electronically in 
clinical practice have been introduced.
3
  The use of electronic databases presents new 
opportunities for physical therapists to contribute important evidence towards the quality 
of care and evaluate what is occurring in clinical practice.   Understanding the differences 
between information gathered in usual clinical practice (observational design) and 
information from a controlled study will assist physical therapists to critically examine 
the evidence presented from different study designs.   
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The purpose of this perspective paper is to review the techniques used to analyze 
the measurement of change within an RCT and to discuss alternative techniques 
developed for use in observational studies.   The objectives will be as follows: 1) to 
identify threats to internal and external validity,  2) to describe two specific study designs 
used to evaluate change, 3) to describe the analysis techniques used to measure change in 
RCT and extrapolate their usefulness in observational studies and 4) to introduce newer 
approaches in study design and the evaluation of change in observational studies. 
 
3.2.1 Threats to internal validity 
 Limiting the threats to the internal validity and potential sources of bias in a study 
can achieve the best approximation of the true difference between groups.  Confounding, 
selection bias and regression to the mean are threats to internal validity that can be found 
in both RCT and observational study designs.   
Confounding is the potential that another variable outside the study variables is 
associated to both the treatment and the outcome,
10
 resulting in an unfair comparison of 
groups.  Some commonly identified confounders are age, sex, or prognostic factors other 
than the ones under study (e.g., comorbidities, duration of symptoms, etc.).  When 
confounders are known and measured in a study, their effects can be identified in the 
analysis.
10
 In addition, there are hidden confounders that may be unknown to the 
investigators and unmeasured.   Hidden confounders are present in every study, but 
because their identity is unknown they cannot be accounted for in the analysis.  Their 
contribution to the outcome cannot be ascertained; thus this lack of control is a threat to 
the internal validity.
18, 30
  Regardless of study design, when confounding factors are 
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known, design and statistical analysis methods can be used to „control‟ the effects of 
confounding to permit valid comparisons between groups.  For example, excluding 
potential participants that have the confounding factor (restriction), stratifying 
participants by the factor (adjustment, standardization) and mathematical modeling 
(regression) are some of the techniques that are used to control for known confounders. 
However, only random assignment can control for the effects of unknown confounders.      
Selection bias can occur as a result of the study design or analysis and is defined 
as differences “in measured and unmeasured baseline characteristics because of the way 
in which participants were selected for the study or assigned to their study groups”. 2  
When participants are randomly assigned to a study group the assumption is that baseline 
characteristics will be equally distributed between groups.  If participants are not 
randomly assigned, there may be a systematic reason that participants were assigned to a 
study group (e.g., healthier patients may be assigned to the more intensive treatment).  
When there is no randomization, group differences are expected resulting in selection 
bias.  Selection bias can also occur if groups within the study differ in participant follow-
up rates.  Loss to follow-up occurs in virtually any study; however, if loss to follow-up is 
associated with factors specific to one treatment group, selection bias results.   For 
example, there may be bias when participants who had undergone total hip arthroplasty 
have their function evaluated at a clinic visit once a month over the first 6 months of 
recovery.  Those with high function may find it easy to physically get to the evaluations 
early in the recovery period and may discontinue evaluations scheduled later in the 
recovery period because of their high function.  Selection bias would result if those with 
low function continued to be followed because they still had remaining functional 
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limitations whereas those with higher levels of function may not be motivated to return 
for follow-up care due to lack of functional limitations.  The study would represent only 
those with lower function and over-represent those with low-function.  In addition, 
selection bias can result during the analysis if there are missing data and analysis is 
performed only on those with complete data.  Many data analysis techniques require an 
entire case to be excluded from analysis if any data point is missing.  If there is a high 
proportion of data excluded from the analysis or if the missing data are distributed 
differently between groups, selection bias is possible.   
A common occurrence in all clinical studies is the threat of regression to the 
mean;  an “observable phenomenon” not related to the treatment effect.19  Regression to 
the mean occurs when there is a tendency for participants who score below the average 
on a measure to improve the next time and conversely, those who scored above the 
average on the measure to decline.  The more a participant deviates from the group mean 
on a measure, the greater the tendency to regress to the mean will be (i.e., it will appear 
as these participants change the most).  Randomization allows equal distribution of 
patients who are above average and below average on important measures to each group, 
thereby minimizing the likelihood that regression to the mean could explain outcome 
differences between groups.
19
  If the randomization procedure, by chance, causes an 
imbalance in the variables related to the outcome across the treatment groups,  regression 
to the mean may still influence the results.
19
  In observational study design where groups 
may be naturally occurring, apparent differences between groups may be influenced by 
different rates of regression to the mean.
19




3.2.2 Threats to external validity 
External validity relates to the extent to which the results can be generalized to 
another situation, population, setting or time period.
10
   Maximizing the external validity 
in a study can provide the best approximation of what is occurring in the real world by 
establishing if the results from studies with high internal validity can be replicated in 
usual clinical practice and what these results mean in the real world.  Low 
generalizability in a study can be a result of very specific or restrictive criteria for subject 
inclusion, measurement instruments, or treatment procedures.  For example, restrictive 
inclusion criteria could yield a group of participants with a better than average prognosis 
who may react differently to a treatment than a more inclusive group of people.  External 
validity could also be compromised if treatment procedures are delivered by highly 
trained individuals whose skill in applying a particular treatment may not be viewed as 
typical of most clinicians.  Finally, the process of requiring an informed consent 
introduces a bias by the potential for subjects who agree to participate may be different 
than those that refuse to participate.  Further, participation in an experiment can result in 
participants behaving differently had they not been involved in the study („Hawthorne 
Effect‟).20  As a result, the study‟s generalizability may be compromised because the 
study results may not be applicable to the nonexperimental setting.   
Study design is a trade-off between internal and external validity which can span 
a continuum from highly favoring internal validity or external validity, to attempt for a 
more balanced approach.  When a study is designed with focus on one validity element, 
the other validity element is compromised (i.e., a high focus on internal validity will 
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result in lower external validity).  Ideally, high levels of both internal and external 
validity are desired but no single study design accomplishes this.   
 
3.3  Randomized clinical trial 
The RCT study design is used in the evaluation of change to determine whether a 
difference exists between two or more groups.
13
  The cornerstone of the RCT study 
design is random assignment of participants to groups, which should create balanced 
treatment groups.
34
  Randomization is assumed to create two groups with equivalent 
baseline characteristics, reducing selection bias and equally distributing hidden variables, 
thereby controlling the effects of confounding.
34
   Even when randomization is used to 
assign participants to treatment groups, the possibility remains that the groups could be 
unbalanced in a meaningful way.  This could occur by chance, particularly in RCTs with 
small sample sizes.  Aspects of how randomization is conducted within a study may also 
be responsible for the failure to produce balanced groups.  In particular, it is important 
that the sequence of randomization is concealed from persons involved in the study (i.e., 
participants, clinicians, investigators, administrators).
10
  If the randomization sequence is 
revealed, there is the potential of selection bias and the possibility groups will differ in 
characteristics.  Successful participant randomization is important as it creates unbiased 
comparison between groups, providing a valid basis for statistical tests of significance.
1
     
In addition to randomization, the RCT study design creates similar treatment 
groups, to reduce confounding, follow-up time points and study variables.  In the RCT, 
restrictions are imposed on the participants recruited by very precise inclusion and 
exclusion criteria.  Further, to reduce the possibility of selection bias during participant 
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follow-up, group balance is maintained after randomization by a process called blinding.  
Blinding is defined as the concealment of the assigned treatment group from the patient, 
the investigator and the outcomes assessor. Blinding to the treatment group encourages 
all groups should be followed with equal rigor because knowledge about which 
intervention each participant is receiving can misrepresent results or conclusions.  
Finally, high control is maintained over the treatment, treatment delivery and delivery 
time by strict study protocols to provide similar treatment for all study participants. 
The high level of control in a RCT reduces bias and increases the internal validity 
allowing causal interpretations to be made on the study population.  The restrictions 
imposed on the RCT have the potential to reduce the level of external validity, causing 
these types of studies to be limited in their ability to generalize to the affected 
population.
6
     
 
3.4  Observational study design 
By design, an observational study lacks randomization in treatment assignment
34
 
and requires the observation or  measurement of outcomes without impacting the 
outcome.
13
  Studies using this design have advantages as the population being studied can 
be diverse, treatments are more likely to be delivered in a manner consistent with clinical 
practice, treatments that may be unethical to withhold in a RCT study design can be 
investigated and these designs can be used to model outcomes in usual practice.   
Although the lack of control imposed in observational study designs can enhance 
external validity, these approaches create biases that limit internal validity.  The primary 
reason for the reduced internal validity is the lack of randomization.   There is selection 
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bias in observational studies because participants are not randomly assigned to a 
treatment group but instead have either chosen their own treatment, or their treatment has 
been imposed upon them (i.e., clinician, family, setting).  The reasons certain participants 
chose or receive a certain treatment are difficult to account for and if these reasons also 
affect the outcome, direct comparison of the groups may result in biased conclusions.  
When there is no randomization, group differences are expected, introducing a risk that 
the difference in outcomes could be due to the initial differences between patient 
groups.
34
  This selection bias results in incorrect treatment effect inferences because of 
the increased threats to internal validity.
12, 30
   
The lack of randomization also results in the potential for the hidden variables to 
be unequal between groups resulting in confounding.
13, 18, 30
   In studies that use a 
secondary data source such as a database, these hidden variables present a problem 
because the choice of data elements in a preexisting database is limited to that which has 
already been collected and often does not include an element that may be desired.
27
   
Randomization is the only strategy to manage hidden variables.  The nonrandomization 
process in observational studies introduces a risk that the difference in outcomes could be 
due to the differences between patient groups. 
The participants in observational studies often have few restrictions placed upon 
their inclusion, allowing a diverse population with a broad spectrum of disease severity
13
  
and attend multiple visits at varying time points.  This lack of restriction can lead to a loss 
of control over variables external to the study.   As a result, there is an increase in the 
possibility of confounding and low internal validity but also an increase in the 
generalizability (external validity) to the affected population.  
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Recent developments in the design of observational studies can assist in 
minimizing threats to internal validity without using randomization.  Matching is a well 
known strategy to manage confounding due to nonrandomization.  An advanced 
matching strategy, the propensity score methodology, was developed to create groups 
that were similar to those found when a randomization process is used. 
5, 31, 34
  The groups 
created by the propensity score can be statistically analyzed with the same assumptions 
and rules that apply to an RCT.
5, 31, 34
    
The propensity score is the predicted probability of being in the treatment 
group(versus control) given the individuals characteristics.
5
  When there are a large 
number of confounders (i.e., age, gender, comorbidities), matching on confounders is 
difficult.  Propensity score matching provides an alternative to individual matching by 
using a group assessment.
17, 32
  The propensity score uses all of the participants‟ 
characteristics (covariates) and reduces these covariates to a single, individual score.  If 
participants have similar propensity scores, then they have similar probabilities of 
receiving the treatment given the measured confounders.
31-32
   
An example of propensity score matching was used by George et al. (2008) to 
investigate the effects of total knee arthroplasty (TKA) on physical functioning in the 
older population.
9
  Using Medicare claims data (n=12,500), 259 participants with 
osteoarthritis of the knee who received a TKA were matched, using a propensity score 
based on demographic characteristics, comorbid conditions and baseline function, to 
1816 participants who did not receive a TKA.  The estimated treatment effect 






3.5  Potential problems in statistical analysis  
To achieve a robust evaluation of change occurring with treatment, it is essential 
that the type of study (i.e., observational or RCT) and the research question being 
investigated match the data analysis technique.  When the same analysis techniques are 
used to evaluate change without consideration of study design, misinterpretation of 
results may occur due to the potential of bias, confounding and regression to the mean.   
A review of the methods and statistical techniques historically associated with each study 
design is necessary to understand how recently developed procedures are applied to the 
evaluation of change. 
35
  Recent advances in methodological and statistical techniques are 
not yet common, but are highly applicable to research related to physical therapy 
treatments.
35
      
The absolute difference, percentage change and baseline adjustment are 
established statistical analysis techniques used to evaluate group differences at two or 
more time points (repeated measures).  In an RCT study design, these techniques can 
minimize error and avoid overestimation of group differences.  In contrast, use of these 
techniques with observational study designs may result in artificial treatment effects due 
to group differences related to extraneous variables.  The lack of randomization of 
participants in an observational study complicates the evaluation of change and requires 
statistical analysis techniques that deviate from the analysis techniques performed with 
randomized clinical trial designs.
25
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3.5.1 Absolute difference  
The absolute difference (change score) is computed as the posttreatment score 
subtracted from the pretreatment score and is used to examine whether two groups differ 
in their mean change over time.  The absolute difference does not control for group 
differences at baseline but rather asks a question “Do these groups differ in their average 
change?”  The absolute difference is appropriate with data derived from a RCT or 
observational study. 
 
3.5.2 Percentage change  
Percentage change (i.e., relative difference) is a unitless number expressed as a 
fraction of improvement [(baseline score – posttest score)/baseline score X 100].  It is a 
description of a percentage gain or loss from the initial value on a particular outcome.  
The main benefit of using the percentage change score may be the ease in the 
interpretation of change.  For example, to describe functional level change after total hip 
arthroplasty(THA) the following statement could be said using percentage change 
analysis On average, the functional level increased 10% for young people after THR, 
whereas it increased 30% for older people.  Whereas using the absolute difference to 
describe the same population may result in a less intuitive description: On average the 
functional level increased 10 units for young people after THA, whereas it increased 20 
units for older people.  
In general, the percentage change score performs poorly when there are 
differences at baseline. Similar to the absolute difference, there may be confounding 
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present because of other measured or unmeasured variables not controlled for in the 
analysis. 
 
3.5.3 Baseline adjustment 
Baseline adjustment uses the pretreatment score as a covariate in a regression 
equation to compare changes between groups.  When groups are randomly allocated, the 
groups are assumed to be equal at baseline.  If by chance there are differences at baseline, 
using the baseline measure as a covariate reduces between-subject variability (i.e., error 
variance-differences due to chance) and statistically creates more similar groups for 
comparison.  When the baseline value is used as a covariate, the question being asked 




In observational studies, baseline differences are expected due to the 
nonrandomized selection.  There is controversy whether or not to adjust for baseline 
difference with those against the use of baseline adjustment with nonrandomized 
groups
11, 15, 28
 and those that recommend its use with caution.
21
  When baseline 
differences exist, those subjects farther away from the mean at their baseline value will 
show greater change, resulting in regression to the mean.
15
  Thus, in observational studies 
where there may be large baseline differences, the baseline value as a covariate can bias 
the estimation and/or detection of treatment effects.
16




3.5.4 Hierarchical linear modeling 
Recently, another analysis technique was developed to address the issues of 
confounding and bias identified in the study design and statistical analysis of RCT and 
observational studies.  Hierarchical linear modeling (HLM) is a newer type of analysis 
that is not constricted by the assumptions and rules imposed when using the classic 
analysis techniques.
14, 29
  HLM can be used to determine individual change over time and 
be used to determine how a person changes independently from the group.  A detailed 
description of the HLM technique
36
 and the application of HLM in physical therapy has 
been described by Stratford(2003) and Resnik(2008).
27, 36
  Briefly, HLM is based on two 
levels of regression equations, within-group (level-1) and between group(level-2).
35
  The 
level-1 equation, answers questions about the change occurring within an individual, 
“How quickly has this person recovered?”35  The level-2 equation answers the question 
about “how individual change differs  from participant to participant.”35  The use of level 
data allows the characteristics of clusters, i.e., a patient, a clinician, a facility or 
geographic area, to be accounted for in the analysis.   The main benefit of the HLM 
technique is many restrictions that apply to the previous analysis techniques (absolute 
difference, percentage change and baseline adjustment) are mitigated.  The HLM 
technique is flexible in the application to time and inclusion of all a participant‟s 
information.  Every data point is considered unique for each participant.   Allowing each 
observation to have a unique time point accommodates measurements that were taken at 
varying time points.  In HLM, the unique time point assignment reduces the possibility of 
selection bias due to missing data points.  All data points remain in the analysis even if an 
observation related to that data point is missing.  If a participant drops out of the study 
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early, his or her data points remain in the analysis and contribute even though he or she 
may not have completed the study.  The application of the classic analysis techniques to 
outcome data collected where multiple visits are recorded at varying time points would 
result in a loss of valuable information and statistical power and may result in missed 
treatment effects.   
 In a recent observational study by Kennedy et al. (2008), repeated functional 
measurements from 84 participants with TKA were analyzed to describe the pattern of 
functional recovery 1 year after TKA.  Participants differed in the number of 
assessments, ranging from two to six visits.  Follow-up times were intentionally varied to 
provide a better indication of change after TKA.  To accommodate the varied number of 
assessments and follow-up times, a HLM analysis, nonlinear mixed-effects, was used.  
Graphing of the predicted functional change identified the greatest improvement in the 
first 3 months after TKA.  This was the first study with TKA participants to use this 
unique study design to model change.   
 
3.6  Discussion 
In this article, the RCT design and the observational study design along with their 
associated statistical techniques are used to evaluate treatment effects in the measurement 
of change are reviewed.  Further, potential problems in study design and statistical 
analysis are outlined and new statistical analysis techniques to manage these problems are 
introduced. It is prudent to appreciate the methodological and statistical analysis options 
that can be applied to different study designs so that valid conclusions about treatment 
effects are established. 
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Historically, the RCT study design appears to be the most frequently used type of 
study design to identify treatment effectiveness in physical therapy.  Recently, the use of 
clinically gathered outcomes data, patient registries and electronic medical records has 
introduced the observational study design as a tool to complement information provided 
by a RCT.  The RCT design has strict conditions that allow causal conclusions based on 
straightforward statistical analysis.  As a result of these strict conditions the application to 
clinical practice may be lost or unknown.   In contrast, observational studies often use 
data originating from clinical practice (i.e., no restrictions).  Using a heterogeneous 
population (i.e., clinical practice) can result in confounding requires advanced statistical 
analysis to ensure valid conclusions are being made.
13
  Propensity score matching is an 
advanced method introduced and recommended for use in observational studies to reduce 
the differences that usually occur between groups.
26
  Creating groups with similar 
characteristics can reduce the statistical analysis problems associated with baseline 
differences.       
The classic statistical analysis techniques (absolute difference, percentage change 
and baseline adjustment) used in RCT and observational study designs have limitations. 
Their use is warranted under the specified conditions.  HLM is a newer statistical analysis 
technique that can be used straightforwardly for both RCT and observational study 
designs.
36
  The benefit of the HLM is that it is able to accommodate the many restrictions 
often noted with the classic statistical analysis techniques.  Perhaps of particular interest 
to clinicians is the ability of the HLM to quantify what is observed within clinical 
practice by modeling the individual change over time and how a person changes 
independently from the group.  In addition, modeling individual change using HLM can 
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allow for the individual characteristics of the clinic and the therapist to be included in the 
evaluation.  
Attention to differences in study designs and statistical analysis is necessary to 
produce valid evidence that can be used to base decisions on treatment effectiveness.  In 
the analysis of change these differences are highlighted and could potentially result in 
spurious conclusions.    To guide and improve the rigor of the development and 
interpretation of studies using RCT and observational study designs, checklists have been 
developed.
2, 13, 18, 22-24, 26, 33, 37
 The Consolidated Standards of Reporting Trials 
(CONSORT ) was developed to identify features of the RCT that should be reported to 
determine the quality of the trial.
2, 22-23, 33
  Similarly, the STrengthening the Reporting of 
OBservational Studies in Epidemiology (STROBE) was produced for observation studies 
to improve the reporting quality.
37
  Further, a series of three articles specifically targeting 
the critical appraisal of observational studies were recently published and provide 




3.7  Conclusion 
 Observational and RCT are complementary study designs that add value to the 
effectiveness of physical therapy treatment.  Awareness of the differences in these study 
designs, how these differences can lead to different study conclusions and how new 
techniques can be used to manage these differences may help to translate research into 
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SILENT MODIFIABLE FACTORS ASSOCIATED WITH 
PHYSICAL FUNCTION IN TOTAL HIP AND 
KNEE ARTHROPLASTY CANDIDATES 
 
4.1  Abstract 
4.1.1  Objective 
To determine the association of five cardiometabolic risk factors (diabetes, 
hypertension, elevated triglycerides, low high density lipoproteins, obesity), and 
metabolic syndrome (MetS) with the level of physical function prior to surgery in 
patients undergoing total knee (TKA) and total hip arthroplasty (THA) surgery.   
 
4.1.2  Methods 
Patient physical function data were retrospectively extracted from a clinical 
orthopedic database between September of 2008 and November of 2010. Comorbidities 
were obtained by chart abstraction. Patients were ≥40 years old with a primary total hip 
or knee arthroplasty. Relationships between MetS and its individual components, and 
physical function were completed using the Lower Extremity Function Scale (LEFS) and 




4.1.3  Results 
A total of 174 total knee and 112 total hip candidates were included in the study.  
For total knee candidates, mean LEFS scores were significantly (p<0.001) and clinically 
lower for patients with MetS (30.0 SD 14.2) than without MetS (39.9 SD 16.0).  Adjusted 
analysis showed that MetS remained significantly associated with reduced 
 lower-extremity physical function; additionally, female sex, chronic back pain and 
insomnia significantly reduced preoperative lower-extremity physical function.  For total 
hip candidates, adjusted analysis found MetS and being female were significantly 
(p<0.05) associated with worse lower-extremity physical function.  MetS was not 
significantly associated with preoperative physical health (PCS) in either the total knee or 
hip candidates.   
 
4.1.4  Conclusions 
Presurgical physical function impacts postoperative outcomes in total joint 
replacement.  Identification of modifiable presurgical patient characteristics may alter the 
management of the total knee or hip arthroplasty candidate.  This study provides evidence 
that MetS, back pain and insomnia are modifiable conditions that influence preoperative 
physical function.  Additional research to better understand patient characteristics, long- 
term outcomes and optimal treatment options in the management of the total hip and knee 





4.2  Introduction 
Knee and hip replacement procedures are an effective treatment for osteoarthritis 
(OA) related pain and dysfunction.
1
   Approximately 15-30% of the total hip and knee 
arthroplasty population does not have substantial improvement in their pain, functional 
status and overall health related quality of life.
2-6
  During the course of the next 20 years, 
the number of TKA and THA procedures are predicted to increase 673% and 174%, 
respectively, resulting in 3.5 million TKA/THA procedures.
7
  As a consequence, over 
half a million people undergoing TKA/THA surgery could have impaired function for 
activities such as walking and stair climbing.  The healthcare resources needed to manage 
these limitations will result in a high economic burden to providers, patients and society. 
Metabolic syndrome (MetS) is defined as the clustering of the following 
cardiovascular risk factors: abdominal obesity, hypertension, dyslipidemia (elevated TG 
and low high density lipoproteins) and elevated fasting glusose.
8
   The prevalence of 
MetS in the U.S. has increased to approximately 34%.
9
  MetS increases the risk of 
cardiovascular disease, stroke and dementia
10-11
 and has a negative impact on quality of 
life.
12
  Hypertension, hypercholesterolemia and elevated blood glucose are associated 
with OA independent of obesity.
13-14
 TKA and THA candidates may have higher 
prevalence of MetS due to cardiovascular risk factors link with OA or simply due to 
inactivity that may accompany joint pain.  Regardess of the cause, MetS has been linked 
to an increased risk of postoperative complications, deep vein thrombosis
15
 and 
pulmonary embolus in the total hip and knee arthroplasty population.
16
 
Individual components of MetS have been investigated in the total joint 
arthroplasty population with conflicting results.  Population-based studies have 
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consistently shown a link between overweight or obesity and knee/hip OA,
17-18
 although 
the impact of obesity on TKA and THA functional outcome is controversial.
19-20
  Patients 
with diabetes reportedly achieve the same level of function as nondiabetic patients but 
take a longer duration of time to achieve similar results.
21-23
  Recently, Gandhi et al. 
(2010) investigated the individual components of MetS and found hypertension and 
obesity to be predictive of poorer outcome following total hip arthroplasty.
24
  There are 
limited data demonstrating the association of physical function outcomes with MetS in 
the total hip and knee arthroplasty population.
25
  
The purpose of this study was to determine the association of each of five 
cardiometabolic risk factors (diabetes, hypertension, elevated triglycerides, low high 
density lipoproteins, obesity) and MetS (three or more risk factors present) with the level 
of physical function prior to surgery in patients with TKA and THA surgery.  The main 
objectives of this study were to:  (1) describe baseline (preoperative) characteristics 
(demographics, LEFS, SF36) between those with and without MetS and (2) explore 
associations between CMR factors on level of physical function adjusting for age, sex, 
physical activity and comorbidity.   
 
4.3  Methods 
4.3.1 Data source 
All questionnaire data were collected as part of routine clinical practice from one 
academic total joint service (knee and hip), located in Salt Lake City from September 1, 
2008 through November 30, 2010.   The University of Utah-Total Joint Service maintains 
an electronic database that store data from all physician-patient encounters.  The database 
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contains basic demographic information about each patient (age, gender, surgical date).  
Clinical outcomes, including a health status measure, region-specific disability score and 
a physical activity level measure, were collected at the beginning of each visit and 
entered into the electronic database.   Medical record chart abstraction was completed to 
identify cardiovascular risk factors and comorbid conditions.  
  
4.3.2 Questionnaires 
The health status measure, the Short Form-36 Medical Outcomes Study (SF-36) 
version 2.0 is a 36-question generic instrument for measuring quality of life.
26-27
 
Reliability and validity have been extensively evaluated in a variety of patient 
populations, including people with total hip and knee arthroplasty and community 
dwelling elderly.
26, 28
 Reliability estimates for physical and mental summary scores 
usually exceed 0.90.
20
  The range of scores vary from 0 to 100 with the lowest score 0, 
indicating the worst possible health and 100 the best health.  The Physical Component 
Summary (PCS) score is based on 21 of the 36 questions.
26-27
 
The Lower Extremity Functional Scale (LEFS)
29
 is a region-specific disability 
questionnaire. It is a 20-item self-report measure designed to assess functional status for 
patients with a variety of conditions affecting the lower extremity.  Each item of the 
LEFS is scored from 0-4, with the final score expressed as a sum out of 80 possible 
points.  Higher scores are associated with higher functional status.  Although the LEFS 
was designed for use with a variety of lower extremity conditions, high reliability 
estimates have been shown in the THA and TKA populations (internal consistency 0.93, 
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ICC 0.85-0.92 and minimally detectable change of 9 points).
29-30
 The LEFS is easy for 
the patient to use and it is quick to administer and score.
29-30
  
The Rapid Assessment of Physical Activity (RAPA) 
31-32
 is a self-administered 
questionnaire developed to assess levels of physical activity among adults older than 50 
years.  Items for the RAPA were developed based on Centers for Disease Control and 
Prevention (CDC) guidelines of 30 minutes or more of moderate physical activity on 
every or most days of the week. The final version is a nine-item questionnaire with a yes 
or no response option.  The total score is from 1 to 7 points, with the respondent’s score 
categorized into one of five levels of physical activity: 1=sedentary, 2=underactive, 
3=regular underactive- light activities, 4= regular underactive and 5= regular active. 
Sensitivity, specificity and predictive value of the RAPA compare well with the 
Community Health Activities Model Program for Seniors (CHAMPS) physical activity 




4.3.3 Cardiometabolic risk  
 Cardiometabolic Risk (CMR) is defined using the National Cholesterol Education 
Program Adult Treatment Panel III (NCEP–ATP III) guidelines established for MetS and 
includes the following five risk factors: blood glucose, waist circumference, high-density 
lipoprotein (HDL) cholesterol, triglycerides (TG), hypertension (HTN).
33
  MetS is the 
clustering of any three of these five risk factors.  The out of range values for each risk 
factor are as follows: fasting plasma glucose ≥126 mg/dL, body mass index >27 kg/m2 , 
triglycerides ≥150 mg/dL, high density lipoprotein <40mg/dL (men) or <50mg/dL 
(women) and elevated blood pressure (Systolic  ≥130 mm Hg or diastolic ≥85 mm Hg).33  
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Determination of the presence of each risk factor was completed using three different 
identification criteria (clinical, diagnostic, and treatment).  Clinical criteria were based on 
laboratory test values, blood pressure, height and weight.  Body mass index (BMI) was 
used as a proxy measure for waist circumference and calculated from the patients’ height 
and weight measurements.  Several studies have concluded that BMI and waist 
circumference are highly correlated.
34-36
  Diagnostic criteria was based on patient self-
report or preoperative report of elevated cholesterol, hypertriglyceridemia, hypertension 
(HTN), diabetes mellitus (DM), and obesity.  Treatment criteria were based on the 
prescriptions recorded (patient self-report or preoperative report) indicating treatment for 
elevated cholesterol, hypertriglyceridemia, HTN, DM, and obesity. Patients identified 
using treatment criteria were those with a prescription for any one of the following drugs 
or drug classes: 1) weight loss agents (sibutramine hydrochloride, orlistat), 2) triglyceride 
lowering agents (fibrates, niacin), 3) antihypertensives (angiotensin converting enzyme-
inhibitors, angiotensin receptor blockers, calcium channel blockers, beta-blockers, 
thiazide diuretics, antihypertensive vasodilators, and combinations of these agents), and 
4) drugs used for diabetes (sulfonylureas, metformin, thiazolidinediones, meglitinides, 
alpha-glucosidase inhibitors, and combinations of the preceding agents).  Patients that 
had at least one of the three criteria of abnormality (clinical, treatment and diagnostic) for 
each of the five risk factors (blood glucose, BMI, HDL, TG, HTN) were classified as 
having elevated risk for that risk factor.  Metabolic syndrome was defined as co-
occurrence of an abnormality in three of the five (blood glucose, BMI, HDL, TG, HTN) 
risk factors.
33





Patient characteristics at baseline included age, sex, and comorbid conditions 
(arthritis, mental health, chronic back pain, cancer, insomnia, osteoporosis, gout, 
coronary artery disease and neuropathy) were collected from the hospital admission 
interview conducted on the day of surgery.  Documentation on the admission form of any 
one of the following words was considered a positive indication of the comorbid 
condition: arthritis (arthritis, osteoarthritis, rheumatoid arthritis, fibromyalgia), mental 
health (depression, anxiety), cancer, insomnia, osteoporosis, gout, coronary artery disease 
(CAD) and neuropathy.  This study qualified for exempt review from the Institutional 
Review Board at the University of Utah.   
 
4.3.5 Subjects 
Patients were included if they met all of the following criteria: age 40 years or 
older on the date of their surgery, and underwent a primary total knee or hip arthroplasty.  
Patients were excluded if they had another hip or knee arthroplasty surgery with a year 
from the index surgery, were missing LEFS or SF-36 scores or if they had a stroke, 
paralysis, or any major neurological disorder or medical condition that impaired 
ambulation. 
A total of 415 and 287 people received a TKA and THA, respectively. Upon 
application of the inclusion criteria, 241 (58.1%) patients with TKA and 175 (61.0%) 





Unadjusted and adjusted models (age, sex, comorbid conditions, activity level) 
were used to evaluate the association of CMR factors with physical function.  The LEFS 
and PCS scores were considered the dependent variables, and the five CMR factors, 
MetS, comorbid conditions and physical activity were the independent variables.  
Statistical analyses were performed using StataCorp. 2009. Stata Statistical Software: 
Release 11. College Station, TX: StataCorp LP. 
 
4.4  Results 
There were 174 TKA study participants consisting of 110 women (63.2%), with a 
mean age (63.8 years, SD 10.2) and mean BMI (31.7 kg/m
2
, SD 7.0).  These individuals 
did not differ by age, BMI or sex from the 111 patients with TKA who were not selected 
(Table 4.1).   
 









Study population Nonparticipants p value 
 
(n=174) (n=111) 
 Total knee arthroplasty 
     Female (n,%) 110 (63) 73 (67) 0.662 
Age, years (mean,SD) 64 (10) 64 (11) 0.713 
BMI, kg/m2 (mean,SD) 32 (7) 32 (8) 0.856 
Total hip arthroplasty (n=112) (n=85) 
 Female (n,%) 64 57.14 50 58.82 0.162 
Age, years (mean,SD) 61.29 11.91 60.25 11.71 0.787 
BMI, kg/m2 (mean,SD) 29.96 6.77 30.15 7.95 0.672 
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Patient characteristics (age, BMI, sex) of the 112 THA study participants were 
similar to the TKA population and also did not differ from those not included in the 
study.   Arthritis, mental health, and chronic back pain were the most common comorbid 
conditions (Tables 4.2 and 4.3).  The majority of the TKA (62.8%) and THA (57.6%) 
study populations were considered to have an underactive or sedentary level of physical 
activity.   
 
4.4.1. Prevalence of individual cardiometabolic risk factors and MetS 
The prevalence of diabetes, elevated BMI, hypertension, elevated cholesterol and 
MetS was higher in patients with a TKA compared to those with a THA (Figures 4.2 and 
4.3).  There was almost double the proportion of diabetes in the TKA population (20.1%) 
compared to THA population (11.7%).  A small percentage, 5%, of the TKA study 
population and 13.4% of the THA population did not have any CMR factors (Figure 4.3).   
TKA and TKA patients classified with MetS were significantly (p<0.05) older, with a 
higher body mass index.  In addition, patients with MetS and a TKA also had 
significantly (p<0.05) lower functional status (LEFS score) than those without MetS.    
 
4.4.2 Association of individual cardiometabolic risk factors and  
MetS on physical function 
4.4.2.1 Univariate associations 
In Table 4.4, the unadjusted models of physical health (PCS), hypertension was 
the only risk factor significantly (p=0.044) associated with lower physical health in 
patients with a TKA; no risk factors were associated with physical health (PCS) for
68 
 




















44 69.84 0.172 




66.16 9.34 0.021 




33.92 7.12 0.002 
         Comorbid conditions (n,%) 
        
 




49 77.78 0.856 
 




27 42.86 0.442 
 




24 38.10 0.075 
 




11 17.46 0.703 
 




16 25.40 0.072 
 




9 14.29 0.754 
 




3 4.76 0.524 
 
Coronary artery 




4 6.35 0.406 
 




2 3.17 0.561 
Physical Function (mean, SD) 
        SF-36 Score* 
         
 




32.69 8.72 0.104 
 




30.02 14.19 0.001 
Physical Activity (n,%) 
         
 
































 *BMI: kg/m2; Lower Extremity functional Scale, Short Form Physical Component Summary Score; test of 
significance are between no metabolic and metabolic syndrome 
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  N=112 n=81 n=31   
Demographics 
       Female      (n,%) 64 57.14 49 60.49 15 48.39 0.247 
Age Mean years (SD) 61.29 11.91 59.52 12.48 65.90 8.90 0.011 
BMI* Mean (SD) 29.96 6.77 28.83 6.96 32.92 5.27 0.004 
       Comorbid conditions (n,%) 
      
 
Arthritis 86 76.79 61 75.31 25 80.65 0.550 
 
Mental health 41 36.61 28 34.57 13 41.94 0.469 
 
Chronic back pain 43 38.39 27 33.33 16 51.61 0.075 
 
Cancer 13 11.61 8 9.88 5 16.13 0.355 
 
Insomnia 14 12.50 8 9.88 6 19.35 0.175 
 
Osteoporosis 21 18.75 14 17.28 7 22.58 0.521 
 
Gout 0 0 
     
 
Coronary artery disease 1 0.89 
     
 
Neuropathy 1 0.89 
     Physical Function (mean, SD) 
       SF-36 Score* 
       
 
PCS  31.91 8.10 32.08 8.86 31.47 5.79 0.723 
 
LEFS*  33.30 17.00 35.20 17.65 28.31 14.23 0.063 
Physical Activity (n,%) 
       
 
Sedentary 5 4.72 3 3.95 2 6.67 0.357 
 
Underactive 5 4.72 5 6.58 0 0 
 
 
Underactive 22 20.75 14 18.42 8 26.67 
 
 
Underactive- regular 29 27.36 19 25.00 10 33.33 
   Active 45 42.45 35 46.05 10 33.33   
*BMI: kg/m2; Lower Extremity functional Scale, Short Form Physical Component Summary Score; test of 
significance are between no metabolic and metabolic syndrome 
          

  
Table 4.4  Unadjusted associations of physical function with individual cardiometabolic risk factors  
and metabolic syndrome 
  Total Hip Arthroplasty Total Knee Arthroplasty 
 
PCS LEFS PCS LEFS 
  Β  (95% CI) p value Β (95% CI) p value Β ( 95% CI) p value Β ( 95% CI) p value 




(-15.23 0.23)   (-3.85   4.02)   (-11.41 2.85)   




(-14.24 5.75)   (-5.50  1.20)   (-14.53 -2.26)   




(-10.23 3.05)   (-5.48   -0.07)   (-12.73 -2.96)   




(-10.23 3.05)   (-3.42   1.95)   (-10.14 -0.28)   




(-21.50 4.79)   (-7.53  10.26)   (-15.85 16.37)   
Metabolic syndrome -0.61 0.723 -6.89 0.063 -2.29 0.104 -9.86 0.000 
  (-4.02 2.80)   (-14.15 0.38)   (-5.05  0.48)   (-14.87   -4.84)   






patients with a THA.  For those with a TKA, the unadjusted variables of diabetes 
(p=0.008), hypertension (p=0.002), elevated cholesterol (p=0.034), and MetS (p<0.001) 
had significant associations with lower-extremity physical function (LEFS).   No 
individual CMR factors or MetS were significantly associated with lower-extremity 
physical function (LEFS) for those with a THA. 
 
4.4.2.2 Multivariate models 
Table 4.5 shows the multivariate regression for the association between the CMR 
factors and physical function (PCS and LEFS).  Each analysis included the following 
covariates: demographic characteristics, comorbid conditions (arthritis, chronic back 
pain, mental health, cancer, insomnia and osteoporosis) and activity level.  
Individual CMR factors (hypertension, elevated triglycerides, elevated 
cholesterol, elevated BMI and diabetes) were not significantly associated with physical 
function for either the TKA or THA population.  For those with a THA, lower physical 
health was associated with female sex (β -4.68; 95% CI -8.15 to -1.21; p=0.009) and 
insomnia (β -6.58; 95% CI -11.06 to -2.11; p=0.004).   
In the TKA population, a decrease in lower-extremity physical function was 
significantly (p<0.05) associated with female sex, chronic back pain and insomnia.  
Patients with a TKA and who were physically active had higher lower-extremity physical 
function scores (β 5.81; 95% CI 1.01 to 10.62; p=0.018) than those who were not active. 
Table 4.6 shows the multivariate regression for the association between MetS and 




Table 4.5.  Multivariate regression results for cardiometabolic risk factors association with physical function in 
patients with hip or knee arthroplasty  
 
 
  Total Hip Arthroplasty Total Knee Arthroplasty 
 
PCS LEFS PCS LEFS 
  B coeff. 95% CI p value B coeff. 95% CI p value B coeff. 95% CI p value B coeff. 95% CI p value 
CMR Factors 








































 Diabetes 0.7 0.783 -1.68 0.765 -0.59 0.747 -4.29 0.167 





















 Age 0.17 0.030 0.04 0.808 -0.01 0.931 -0.12 0.349 



















Table 4.5.  (continued) 
 
 
  Total Hip Arthroplasty Total Knee Arthroplasty 
 
PCS LEFS PCS LEFS 
  B coeff. 95% CI p value B coeff. 95% CI p value B coeff. 95% CI p value B coeff. 95% CI p value 
Comorbid Conditions 






















































 Physical Activity -0.19 0.905 -1.63 0.637 2.59 0.072 5.81 0.018 











 Table 4.6. Multivariate regression results for the association of metabolic syndrome with physical function in patients with hip 
or knee arthroplasty  
 THA TKA 
 PCS LEFS PCS LEFS  
 β (95% CI)  β (95% CI β (95% CI  β (95% CI  
Metabolic Syndrome -2.10 p=0.224 -7.98 p=0.041 -1.17 p=0.415 -5.95 p=0.017 
 ( -5.50  1.30) 
 
(-15.62  -0.34) 
 
(-4.01 1.66)  (-10.81  -1.09) 
 DEMOGRAPHICS     
  
  0. 077     
Female -4.88 0.001 -7.72 0.041 -2.56  -4.99 0.044 




(-5.40 0.30  (-9.84 -0.15) 
 Age  0.19 0.008 0.10 0.504 -0.04 0. 573 -0.11 0.373 




(-0.18 0.10)  (-0.35 0.13) 
 COMORBIDITIES     
  
     
 Arthritis -.29 0.871 -0.78 0.845 -0. 88 0. 600 -1.43 0.622 




(-4.23 2.45)  (-7.13 4.28) 
 Chronic back pain -1.82 0.242 -3.33 0.336 -3.88 0. 010 -8.40 0.001 




(-6.83 -0.94)  (-3.41 -3.39) 
 Mental health 130 0.404 -3.79 0.274 -0.06 0. 961 -3.15 0.196 




(-2.74 2.88)  (-7.97 1.65) 
 Cancer 2.60 0.272 -0.46 0.931 1.56 0. 365 -0.95 0.745 




(-4.95 1.83)  (-6.72 4.82) 
 Insomnia -6.27 0.005 -5.54 0.251 -3.94 0. 025 -9.06 0.003 




(-7.37 -0.51)  (-15.00 -3.11)   
Osteoporosis -4.20 
 
-3.44 0.495 0.58 0.776 1.27 0.712 
  (-8.66 0.26) 0.065 (-13.42 6.54) 
 
( -3.46 4.63)  (-5.52 8.06)   
ACTIVITY LEVEL      
  
       
Physically Active 0.007 0.965 -0.90 0.788 2.76  0.050 6.34 0.009 




(-0.01 5.53)  (1.64 11.04)   





conditions (arthritis, chronic back pain, mental health, cancer, insomnia and osteoporosis) 
and activity level.  For those with a THA, MetS (β -7.98; 95% CI -15.62 to -0.34, 
p=0.041) and female sex (β -7.72; 95% CI -15.11 to -0.34; p=0.041) were significantly 
associated with decreased lower-extremity physical function.  For physical health (PCS), 
female sex (β -4.88 95% CI -8.19 to -1.15; p=0.001), and having insomnia (β -6.27; 95% 
CI -10.59 to -1.96; p=0.005) were significantly associated with decreased physical health 
(PCS).  Physical activity was not associated with physical function (PCS and LEFS). 
For patients with a TKA, MetS, female sex, chronic back pain and insomnia were 
shown to decrease preoperative lower-extremity physical function.  Those with insomnia 
had the largest reduction (9 points on the LEFS) of preoperative lower-extremity physical 
function (β 9.06; 95% CI -15.00 to -3.11; p=0.003). For physical health (PCS), only 
chronic back pain was associated with reduced preoperative physical health (β -3.88; 
95% CI -6.83 to -0.94; p=0.010).   The patients with a TKA that were also physically 
active prior to surgery, had increased preoperative values (p<0.05) of physical health and 
lower-extremity physical function.  
 
4.5  Discussion 
This study provides preliminary evidence on the association of both individual 
CMR factors and MetS on the presurgical physical function score using two measures of 
physical function: lower-extremity physical function (LEFS) and physical health (SF-36).  
In our study, we found patients with total knee/hip arthroplasty and MetS had 
significantly worse preoperative levels of lower-extremity physical function than those 
without MetS; there was no significant difference found in preoperative physical health.   
77 
 
There is limited data in the total arthroplasty population demonstrating the health 
consequences of MetS.
24
   It has been suggested that MetS could influence physical 




 and low muscle 
strength.
39
 Only one study has investigated the influence of risk factors of MetS on 
presurgical physical function in patients with a TKA or THA.
24
  Risk factors were 
grouped together by the number of metabolic abnormalities and adjusted for age, sex and 
comorbidity.   They found those with three risk factors (MetS) in the TKA population and 
four risk factors in the THA population had worse presurgical physical function.
24
  Our 
study supports these findings, suggesting that MetS may affect preoperative physical 
function in those undergoing total hip or knee arthroplasty. 
24
  
A higher physical function score has indicated a better postoperative recovery 
physical function, in the total knee and hip arthroplasty population.
40-42
  Little is known 
about patient characteristics that may influence the presurgical function.  In addition to 
the association of MetS with preoperative lower extremity physical function in patients 
undergoing TKA and THA, we found patient sex (female), comorbidity (chronic back 
pain and insomnia) and physical activity, contributed significantly to physical function.   
The presence of back pain, in the TKA population, has been identified as a 
preintervention predictor of worse outcome postarthroplasty.
40, 43
  In our study, the 
patients with a TKA and concomitant chronic back pain also had worse preoperative 
physical function (lower-extremity and physical health).  This effect was not seen in the 
THA population.   
Good quality sleep is a critical for good health.
44
  In the older population in 
general, sleep disturbances have been associated with a decrease health related quality of 
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life and physical function.
44
  In the TKA/THA population, sleep disturbance has been 
shown to predict postoperative complications.
45-46
   Our results indicate that insomnia is 
associated with worse preoperative physical health in both the THA and TKA 
populations.  To our knowledge, this is the first report of sleep disturbance with 
functional outcomes prior to joint arthroplasty.   Pain, backache and discomfort are 
proposed reasons for sleep disturbance in the total joint arthroplasty populations.  It has 
been suggested that the treatment of the sleep symptoms may actually improve the 
patient's ability to function.




 Our finding that women have worse presurgical physical function than men is 
supported in the total joint arthroplasty literature.
51-53
  Women start the surgical process at 
a worse functional status than men, and do not attain the postoperative level of physical 
function that men achieve.
54-55
  Further investigation is warranted to understand the sex 
related differences in preoperative physical function to target specific variables prior to 
surgery that may be unique to women.
51
  
Regular physical activity can enhance musculoskeletal fitness, which is positively 
associated with functional mobility.
56
 A significant improvement in lower-extremity 
physical function and physical health was found in patients with a TKA that were 
physically active however being physically active prior to surgery did not influence the 
physical function of the THA population.  Preliminary evidence suggests hip and knee 
arthroplasty patients respond differently in the preoperative period.
57
  It would seem that 
a preoperative exercise program may help to increase physical function; the data related 





Further research is needed to understand the potential role that physical activity plays in 
the preparation for surgery. 
 Our study has several limitations.  This cohort was based from a single academic 
center orthopedic practice which may consist of patients with conditions that are more 
complicated than typically seen in the general total hip or knee arthroplasty population. 
Although when our study population’s preoperative lower-extremity physical function 




This study used physical function data gathered from routine clinical practice 
which resulted in a high number of patients that did not complete a preoperative measure 
of physical function.  The individuals not included in this study were similar in age and 
body mass index compared to the individuals in the study but information on physical 
function and comorbidity prevalence was unknown and may have biased the results.   
Due to the high reported prevalence of undiagnosed CMR factors, particularly the 
high rate of undiagnosed and/or untreated cardiometabolic risk in women, we may have 
underestimated the prevalence of MetS and its individual components.
61
   Future research 
should incorporate current guidelines recommending a comprehensive assessment of 
CMR
 
risk in both men and women.
62-64
  The evaluation should
 
include a complete a 
medical and family history to identify the presence
 
of a known history of cardiometabolic 
disease, and a laboratory assessment (complete lipid panel and
 




4.6  Summary 
Presurgical physical function impacts postoperative outcomes.  MetS, back pain, 
and insomnia are modifiable conditions that influence preoperative physical function.  
Identification and management of modifiable presurgical factors that impact preoperative 
physical function may lead to improved postoperative outcomes.  Future research is 
needed to evaluate whether these conditions influence postoperative outcomes.   
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ASSOCIATION OF CARDIOMETABOLIC RISK AND PHYSICAL 
FUNCTION AFTER TOTAL KNEE OR HIP ARTHROPLASTY 
 
5.1  Abstract 
5.1.1  Objective 
To determine the association of five cardiometabolic risk (CMR) factors 
(diabetes, hypertension, elevated triglycerides, low high density lipoproteins, obesity), 
and metabolic syndrome (MetS), the presence of three of the five CMR factors, with 
physical function 6-weeks after surgery in patients with total knee (TKA) and total hip 
arthroplasty (THA) surgery adjusting for age, sex, physical activity, comorbidity and 
preoperative physical function.   
 
5.1.2  Methods 
Patient physical function data were retrospectively extracted from a clinical 
orthopedic database Sept 1, 2008 to November 30, 2010. Comorbidities were obtained by 
chart abstraction. Patients were ≥40 years old with a primary total hip or knee 
arthroplasty. Relationships between MetS and its’ individual components, and physical 




physical component score (PCS).  Covariates were age, sex, comorbidities, and physical 
activity. 
 
5.1.3  Results 
A total of 170 and 111 patients with a total knee and total hip arthroplasty, 
respectively, were included in the study.  For total knee patients, mean preoperative 
LEFS scores were significantly (p<0.001) and clinically lower for patients with MetS 
(29.8 SD 14.3) than without MetS (40.1 SD 16.0).  Postoperatively, the adjusted analysis 
showed that of the CMR factors, only diabetes remained significantly associated with 
reduced lower-extremity physical function.  Chronic back pain and presurgical physical 
function significantly reduced postoperative lower-extremity physical function.  For total 
hip patients, adjusted analysis found being female, chronic back pain and presurgical 
physical function were significantly (p<0.05) associated with worse physical health.  In 
the adjusted models, MetS was not significantly associated with postoperative physical 
function (PCS or LEFS) in the THA/TKA population.   
 
5.1.4  Conclusions 
Identification of modifiable patient characteristics may alter that management of 
the total knee or hip arthroplasty candidate.  This study provides evidence that presurgical 
physical function, diabetes and back pain are modifiable conditions that influence 
postoperative physical function.  It is known that presurgical physical function impacts 
postoperative outcomes.  MetS, back pain and diabetes were found to influence 




preoperative patient characteristics that influence physical function, such as chronic back 
pain, diabetes, insomnia and MetS can be mediated to increase prefunctional status and 
potentially increase long-term postoperative outcomes as the optimal treatment options in 
the management of total hip and knee arthroplasty population is warranted. 
 
5.2  Introduction 
The estimated total hospital cost per year for joint replacements (2004) was $30 
billion.
1
  The demand for hip and knee replacements is rising annually and growth is 
expected to be substantial with a doubling in the number of hip procedures and a five-
fold increase in knee replacements compared to 2005.
2
  As a result, there will be an 
exponential increase in the healthcare resources needed to manage the postoperative care 
of the total hip and knee arthroplasty population.  To optimize resource utilization it will 
be important to identify the patients which would benefit from pre- and/or 
postarthroplasty medical and /or rehabilitation management.   
 There is evidence that the presence and number of comorbidities is related to 
disability and physical function outcomes in the total hip and knee populations.
3-5
 There 
are no clear indications, however, of specific modifiable disease conditions in the 
arthroplasty population that may be adversely impacting the recovery of physical 
function. The majority of studies focus on a comorbidity count derived from a wide-
ranging selection of conditions not necessarily related to total hip and knee population.  
Identifying the specific comorbidities that can be modified both pre- and postoperatively 
and determining how these changes are related to physical functioning should improve 




The clustering of  five cardiometabolic risk factors, abdominal obesity, 
hypertension, dyslipidemia ( elevated TG and low high density lipoproteins) and elevated 
fasting glucose, defines metabolic syndrome (MetS).
6
   The prevalence of metabolic 
syndrome in the U.S. has increased to approximately 34%.
7
  Metabolic syndrome 
increases the risk of cardiovascular disease, stroke and dementia
8-9
 and has a negative 
impact on the quality of life.
10
 In the TKA and THA population, MetS has been linked to 
risk of postoperative complications.
11-12
  Complications have been shown to be much 
higher in those patients with risk factor component of metabolic system, obesity, diabetes 
and hypertension.
13-16
  TKA and THA patients may also have a higher prevalence of 
metabolic syndrome due to the cardiometabolic risk factors link with individuals with 
OA.
17
  Finally, the influence metabolic syndrome and its components may have on 
postoperative physical function is not well established.
18
  
The purpose of this study was to determine the association of five cardiometabolic 
risk factors (diabetes, hypertension, elevated triglycerides, low high density lipoproteins, 
obesity) and MetS with physical function 6 weeks after surgery in patients with TKA and 
THA surgery adjusting for age, sex, physical activity, comorbidity and preoperative 
physical function.   
 
5.3  Methods 
5.3.1 Data source 
All questionnaire data were collected as part of routine clinical practice from one 
academic Total Joint Service (knee and hip), located in the Salt Lake City region from 




Service maintains an electronic database that store data from all physician-patient 
encounters.  The database contains basic demographic information about each patient 
(age, gender, surgical date).  Clinical outcomes, including a health status measure, 
region-specific disability score and a physical activity level measure, are collected at the 
beginning of each visit and entered into the electronic database.   Medical record chart 
abstraction was completed to identify cardiovascular risk factors and comorbid 
conditions.   
 
5.3.2 Questionnaires 
The health status measure, the Short Form-36 Medical Outcomes Study (SF-36) 
version 2.0, is a generic instrument for measuring quality of life and has been used 
extensively to evaluate people with total hip and knee arthroplasty.
19-21
  Score values 
range from 0 (worst possible health) to 100 (best health).  The Physical Component 
Summary (PCS) score is based on 21 of the 36 questions (reliability >0.90).
19-20, 22
   
A region-specific disability questionnaire, the Lower Extremity Functional Scale 
(LEFS), is a short (20-item) measure designed to assess functional status for patients with 
a variety of conditions affecting the lower extremity.
23
  Scores range from 0 (worst 
possible physical function) to 80 (best physical function), with high reliability estimates 
in the THA and TKA populations (internal consistency 0.93, ICC 0.85-0.92 and 
minimally detectable change of 9 points).
23-24
 The LEFS is easy for the patient to use and 
it is quick to administer and score. 
23-24
  
The Rapid Assessment of Physical Activity (RAPA) is a self-administered 






  The RAPA was developed based on Centers for Disease Control and 
Prevention (CDC) guidelines of 30 minutes or more of moderate physical activity on 
every or most days of the week(sensitivity 81%, specificity69% positive predictive value 
77%, negative predictive value75%).
25-26
  The total score is from 1 to 7 points, with the 
respondent’s score categorized into one of five levels of physical activity: 1 (sedentary), 2 
(underactive), 3 (regular underactive-light activities) 4 (regular underactive) and 5= 





5.3.3 Cardiometabolic risk  
Cardiometabolic Risk (CMR) is defined using the National Cholesterol Education 
Program Adult Treatment Panel III (NCEP–ATP III) guidelines established for metabolic 
syndrome and includes the following five risk factors: blood glucose, waist 
circumference, high-density lipoprotein (HDL) cholesterol, triglycerides (TG), high 
blood pressure (HBP).
27
  The out of range value for each risk factor are as follows: 
fasting plasma glucose ≥126 mg/dL, body mass index >27kg/m2 , triglycerides ≥150 
mg/dL, high density lipoprotein <40mg/dL (men) or <50mg/dL (women) and elevated 
blood pressure (Systolic  ≥130 mm Hg or diastolic ≥85 mm Hg). 27  Determination of the 
presence of each risk factor was completed using three identification criteria (clinical, 
diagnostic and treatment).  Clinical criteria were based on laboratory test values, blood 
pressure, height and weight.  Body mass index (BMI) was used as a proxy measure for 
waist circumference and calculated from the patients’ height and weight measurements.  






 Diagnostic criteria were based on patient self-report or preoperative report 
of elevated cholesterol, hypertriglyceridemia, hypertension(HTN), diabetes(DM) and 
obesity.  Treatment criteria were based on the prescriptions recorded (patient self-report 
or preoperative report) indicating treatment for elevated cholesterol, 
hypertriglyceridemia, HTN, DM and obesity. Patients identified using treatment criteria 
were those with a prescription for any one of the following drugs or drug classes: 1) 
weight loss agents (sibutramine hydrochloride, orlistat), 2) triglyceride lowering agents 
(fibrates, niacin), 3) antihypertensives (angiotensin converting enzyme-inhibitors, 
angiotensin receptor blockers, calcium channel blockers, beta-blockers, thiazide diuretics, 
antihypertensive vasodilators and combinations of these agents) and 4) drugs used for 
diabetes (sulfonylureas, metformin, thiazolidinediones, meglitinides, alpha-glucosidase 
inhibitors and combinations of the preceding agents).  Patients who had at least one of the 
three criteria of abnormality (clinical, treatment and diagnostic) for each of the five risk 
factors (blood glucose, BMI, HDL, TG, HTN) were classified as having elevated risk for 
that risk factor.  Metabolic syndrome was defined as co-occurrence of an abnormality in 
three of the five (blood glucose, BMI, HDL, TG, HTN) risk factors. 
27
    
 
5.3.4 Demographics 
  Patient characteristics at baseline included age, sex and comorbid conditions 
(arthritis, mental health, chronic back pain, cancer, insomnia, osteoporosis, gout, 
coronary artery disease and neuropathy) were collected from the hospital admission 
interview which is routinely conducted on the day of surgery by a nurse.  Documentation 




indication of the comorbid condition: arthritis (arthritis, osteoarthritis, rheumatoid 
arthritis), mental health (depression, anxiety), chronic back pain, cancer, sleep disorder 
(sleep apnea, insomnia) osteoporosis, gout, coronary artery disease (CAD) and 
neuropathy.  This study qualified for exempt review from the Institutional Review Board 
at the University of Utah.   
 
5.3.5 Subjects 
Patients were included if they met all of the following criteria: age 40 years or 
older on the date of their surgery and underwent a primary total knee or hip arthroplasty.  
Patients were excluded if they had another knee arthroplasty or hip surgery within a year 
from the index surgery, were missing LEFS or SF-36 scores and if they had a stroke, 
paralysis, or any major neurological disorder or medical condition that impairs 
ambulation. 
A total of 415 and 287 people received a TKA and THA, respectively. Upon 
application of the inclusion criteria, 245(59%) patients with TKA and 176 (61%) with 
THA were excluded (Figure 5.1).  
 
5.3.6 Statistical analysis 
To describe the sample, means, standard deviations (SD), frequencies and 
percentages were used.  Comparisons were made on and between the study population 
and those not in the study using a t-test for continuous variables (body mass index, 
[BMI], age) and chi-square test for dichotomous variables (sex).  For all evaluations, 





5.3.6.1   Postsurgical physical function 
Univariate analysis using unadjusted linear regression was used to evaluate 
whether there was an association between cardiometabolic risk (MetS, the individual 
CMR factors) and the covariates (demographics, comorbid conditions and physical 
activity) with physical function (PCS and LEFS scores) at 6 weeks.   This unadjusted 
analysis illustrates the association between variables without consideration for other 
potentially influential variables.  The results are reported using β-coefficients, their 95% 
confidence intervals and p-values.     
A multivariable analysis was used to evaluate if MetS and the individual CMR 
factors were associated with physical function (PCS and LEFS scores) at 6 weeks 
postoperatively, accounting for other influential variables.  Two multiple linear 
regression models were used with MetS and the individual CMR factors as the 
independent variables while adjusting for the potential influence of the demographic 
characteristics, comorbid conditions, activity level and physical function scores prior to 
surgery.  This adjusted model accounts for the known variables that may be influencing 
the 6-week postoperative physical function. The results are reported using β-coefficients, 
their 95% confidence intervals and associated P values.  
 
5.4  Results 
We had pre- and postoperative data on 170 patients with TKA and 111 patients 
with THA.  There were no significant differences in age, BMI or sex between those 





Table 5.1 Description between TKA and THA study population and nonparticipants  
  Study population Non participants p value 
        
Total Knee Arthroplasty n=170 n=115 
 Female (n,%) 107 62.94 71 61.74 0.0930 
Age, years (mean,SD) 64.17 10.10 62.95 10.44 0.3251 
BMI, kg/m
2
 (mean,SD) 31.81 6.93 33.11 8.52 0.1599 
Total Hip Arthroplasty  n=111 n=86 
 Female (n,%) 63 56.76 51 59.30 0.1288 
Age, years (mean,SD) 61.15 11.89 60.51 11.81 0.7067 
BMI, kg/m
2
 (mean,SD) 29.99 6.79 30.30 8.05 0.7705 
 
 
At baseline, the mean patient age of patients with a THA and TKA was 61.36 yrs 
(SD 11.94 yrs) and 63.66 yrs (SD 10.22 yrs); mean BMI was 31.69 kg/m
2
 (SD 7.05) and 
29.99 kg/m
2
 (SD 6.79), respectively.  The majority of the THA (n=64; 57.66%) and TKA 
(n=106; 62.35%) patients were women.  The prevalence of metabolic syndrome (MetS) 
and the individual cardiometabolic risk factors for patients with a TKA or THA were 
MetS (61; 35.88% vs 31; 27.68%), diabetes (34; 20.00% vs 13; 11.71%), elevated 
cholesterol (81; 47.65% vs 41; 36.94%), elevated triglycerides (4; 2.35% vs 9; 8.11%) 
and elevated BMI (147; 86.47% vs 84, 75.68%). Patients with a TKA and metabolic 
syndrome were significantly older (65.9 yrs; SD 9.3 vs 62.4 years; SD 10.50; p=0.031) 
and had a higher BMI (34.00 kg/m
2
; SD 7.20 vs 30.4 kg/m
2
; SD 6.65; p=0.002) than 
those without metabolic syndrome.  A similar pattern was seen in patients with a THA. 
Tables 5.2 and 5.3 describe the pre- and postoperative physical function and the 






overall population and cardiometabolic risk (MetS and the individual CMR factors).    
Overall by cohort, there were significant improvements in physical function from 
baseline to 6 weeks after surgery.  In the TKA and THA cohorts, those with MetS or an 
individual CMR factor had lower preoperative physical function scores than those 
without cardiometabolic risk.  Those patients with diabetes and MetS had the lowest pre-
and postoperative LEFS scores.     
 
5.4.1 Postoperative physical function 
Univariate analysis was used to evaluate whether MetS and the individual CMR 
factors were associated with physical function at 6 weeks.  The unadjusted analysis is 
reported in Table 5.4 for both the TKA and THA populations.  For the THA cohort, 
worse 6-week postoperative physical function (LEFS and PCS) was significantly 
(p<0.05) associated with sex (female), chronic back pain and osteoporosis.  An improved 
physical function was seen in those with a THA who were also physically active 
(p=0.009).  For the TKA population, diabetes, MetS and chronic back pain were 
significantly (p<0.05) associated with 6-week postoperative lower-extremity physical 
function whereas only chronic back pain was significantly associated with physical 
health.  
 To evaluate if other variables were contributing to physical function at 6 weeks 
postsurgery, a multivariable analysis was completed with all the univariate variables  
remaining in the model with the addition of preoperative physical function.  The 
multivariable analysis for the association of the individual cardiometabolic risk factors 





and covariates (demographic characteristics, comorbid conditions and activity level) with 
physical function for the TKA and THA populations are shown separately on Table 5.5.   
The multivariable analysis for the association of MetS with physical function adjusting 
for covariates is shown in Table 5.6.  
For the knee cohort, worse lower-extremity function (LEFS) at 6-weeks 
postsurgery was significantly associated with diabetes (β -7.43 CI -13.13 to -1.74, 
p=0.011) and chronic back pain (β -6.97, CI -11.79 to -2.15, p=0.005).    Those with 
hypertension had significantly lower preoperative scores of physical function and 
significantly increased postoperative scores of physical function (PCS: β2.93; 95% CI 
0.09 to 5.77, p=0.043) and lower-extremity function (LEFS: β 6.67, CI 1.94 to 11.40, 
p=0.006); no significant difference was found in unadjusted postoperative physical 
function  between those with and without hypertension.  These results  indicate that those 
with and without hypertension achieved similar levels of physical function recovery at 6 
weeks, but those with hypertension had increased physical function since baseline 
because they started lower (Table 5.5).  In the MetS multivariable model, only chronic 
back pain remained significantly associated with lower-extremity physical function (β -
7.53 95% CI: -12.46 to -2.60) (Table 5.6).   
For the hip cohort, neither MetS nor the individual cardiometabolic risk factors 
were associated with physical function after controlling for demographics, comorbidities, 
preoperative physical function and physical activity.   Two covariates, chronic back pain 
and the preintervention physical function score, were significantly associated with 
physical health and lower extremity function at 6 weeks postsurgery (Table 5.5).   Those  
 Table 5.5  Adjusted association of cardiometabolic risk factors, demographic, 
comorbid conditions and physical activity with physical health (PCS) and lower 
extremity physical function (LEFS) for patients 6 weeks after THA or TKA surgery 
 
  THA TKA 
 
PCS LEFS PCS LEFS 
  β 95%CI p value β 95%CI pvalue β 95%CI p value β 95%CI p value 
CARDIOMETABOLIC RISK FACTORS 
  
   
 
  
   Elevated 2.20 0.291 0.83 0.826 0.84 0.656 3.31 0.293 
BMI -1.92 6.33   -6.65 8.31   -2.88 4.57   -2.89 9.51 
 Diabetes -2.59 0.339 0.90 0.859 -0.97 0.568 -7.43 0.011 
 
-7.95 2.77   -9.19 11   -4.33 2.39   -13.1 -1.7 
 Hypertension 0.59 0.756 -1.16 0.739 2.93 0.043 6.67 0.006 
 
-3.16 4.34   -8.04 5.73   0.09 5.77   1.94 11.4 
 Cholesterol -0.38 0.846 3.44 0.322 -0.70 0.592 0.11 0.960 
 
-4.22 3.47   -3.43 10.3   -3.29 1.89   -4.23 4.45 
 Elevated TG -1.76 0.608 -0.05 0.994 0.94 0.813 1.20 0.857 





   
 
  
   Female -0.86 0.657 -7.86 0.023 1.26 0.356 0.36 0.876 
 
-4.72 2.99   -14.6 -1.1   -1.43 3.94   -4.23 4.96 
 Age  0.12 0.165 0.20 0.192 -0.02 0.829 -0.11 0.344 
  -0.05 0.29   -0.1 0.5   -0.16 0.12   -0.34 0.12   
COMORBID CONDITIONS   
  
   
 
  
   Arthritis 0.19 0.923 0.21 0.956 -2.78 0.085 -3.52 0.202 
 
-3.77 4.15   -7.3 7.72   -5.96 0.39   -8.95 1.91 
 Chronic back -5.02 0.005 -8.72 0.007 -2.61 0.07 -6.97 0.005 
pain -8.47 -1.6   -14.9 -2.5   -5.43 0.21   -11.8 -2.2 
 Mental  0.83 0.630 -0.32 0.923 -1.83 0.194 -3.79 0.116 
health -2.59 4.26   -6.84 6.2   -4.6 0.94   -8.54 0.95 
 Cancer -2.49 0.339 -3.08 0.494 -1.35 0.403 -1.92 0.487 
 
-7.63 2.66   -12 5.84   -4.52 1.82   -7.36 3.52 
 Insomnia -0.90 0.723 -0.16 0.970 1.90 0.246 3.58 0.208 
 
-5.9 4.11   -8.43 8.12   -1.32 5.12   -2.02 9.18 
 Osteoporosis -1.70 0.512 -0.03 0.995 3.09 0.11 5.70 0.073 
  -6.82 3.42   -9.28 9.22   -0.71 6.89   -0.53 11.9   
Physically 3.51 0.038 7.57 0.013 0.70 0.597 -1.22 0.593 
Active 0.19 6.83   1.61 13.5   -1.92 3.32   -5.72 3.28   
Pre-surgical 
0.51 0.000 0.43 0.000 0.38   0.000 0.37 0.000 PCS 
 5.6  Adjusted multivariable regression of metabolic syndrome, demographic, comorbid conditions and physical activity 




PCS LEFS PCS LEFS 
 
β 95% CI pvalue β 95% CI pvalue β 95% CI pvalue β 95% CI pvalue 
Metabolic 





























































































































































































with chronic back pain had lower 6-week postoperative PCS scores by 5.0 points (95%CI 
-8.47 to -1.57, p=0.005) and LEFS score by 8.7 points (95% CI -14.93 to -2.50, p=0.007) 
also indicating clinically significant differences.   Unique to the THA cohort, physical 
activity and sex were found to be associated with postsurgical physical function.  
Physical activity increased both physical health (β 3.51, CI 0.19 to 6.83, p=0.038) and 
lower extremity function (β 7.57, CI 1.61 to 13.53, p=0.013) 6 weeks postoperatively.  
Women were found to have reduced lower-extremity function 6 weeks after surgery 
compared to men (β -7.86, CI -14.62 to-1.09, p=0.023).   
MetS was not significantly associated with physical function at 6 weeks after 
surgery for either the TKA or THA group after controlling for covariates (Table 5.6).   
 
5.5  Discussion 
This aim of this study was to evaluate whether cardiometabolic factors are 
associated with postoperative TKA/THA physical functional recovery.   This study 
confirms previous knowledge of improvement in physical function postoperatively.
31
   In 
the THA and TKA populations, MetS was not associated with 6-week postoperative 
physical function.  In patients with a TKA, we found diabetes was significantly 
associated with worse lower-extremity physical function at 6-weeks. Concomitant pre-
intervention variables (sex, chronic back pain, physical activity and presurgical level of 
physical function) had significant impact on postsurgical physical function.  Specifically, 
chronic back pain and level of physical function prior to surgery had a significant impact 




pain, being physically active prior to surgery and presurgical level of physical function 
had significant impact on postsurgical THA lower extremity physical function. 
 
5.5.1 Cardiometabolic risk  
There are limited data in the total arthroplasty population demonstrating the 
health consequences of MetS.
18
  Previous research has documented that the individual 
components of MetS and MetS are risk factors for osteoarthritis.
32-34
  It has been 





 and low muscle strength.
37
  In this study, the only association with 
MetS and postoperative physical function was found in the univariate analysis with TKA 
patients.  No associations with MetS and physical function were found with the THA 
population.  However, the TKA MetS-postoperative physical function relationship did 
not remain when the covariates were added into the model, suggesting that the covariates, 
chronic back pain and presurgical level of physical function are stronger indicators than 
MetS of low postoperative physical function.     
Of the individual CMR factors, only diabetes was predictive of poorer physical 
function following TKA surgery.   None of the individual CMR factors were predictive 
of physical function after THA.  Our results contradict the findings reported by Gandhi et 
al.(2010).  They found worse outcome was associated with hypertension and obesity in 
the THA population while only obesity was predictive of poor outcome in the TKA 
population.  Our study and the study by Gandhi et al.(2010)
18
 are the first two studies to 




Further studies are required to establish if the presence of MetS and the individual CMR 
factors are predictive preoperative variables that impact postoperative outcomes.   
 
5.5.2 Preoperative physical function and chronic back pain   
Our study supports previous findings that have identified the importance of 
preoperative level of physical function as an indication of postoperative TKA recovery.
4, 
38-39
   We investigated the relationship between preoperative physical function and MetS 
and the individual CMR factors.  Our findings indicate that the presence of 
cardiometabolic risk (MetS and the individual CMR factors) is associated with worse 
preoperative level of physical function.  Future research should focus on identifying what 
influences preoperative physical function and strategies to improve the preoperative level 
of physical function from a broad prospective.  To date, previous research aimed at 
improving preoperative physical function has focused on improving the strength and 
endurance around the hip or knee and the results of these physical exercise programs are 
inconclusive.
40-46
  Preoperative management should include risk-factor recognition and 
subsequent modifications designed to treat the components of MetS prior to surgery.  
Targeting those with MetS and the individual components may lead to improved physical 
function before surgery thereby impacting physical function after surgery 
Previous studies have identified the presence of back pain as a preintervention 




  Our study supports this finding, 
preoperative chronic back pain was significantly associated with worse postoperative 
physical health and lower-extremity physical function in the TKA/THA populations.  




degenerative joint disease in both the hip and spine resulting in difficulty differentiating 
between symptoms caused by a spine disorder or a hip disorder,
47, 50
 poor spinal sagittal 
alignment,
51
 leg length discrepancy that disrupts gait,
52
 and the presence of preexisting 
dormant back pain that may be exacerbated during the perioperative recovery.
53
  There 
has been less attention placed on the relationship between back pain and knee 
dysfunction.  Recent studies have established a link between decreased physical function 
and the presence of back pain in the total knee and total knee revision populations.
4, 49, 54
    
Explanations for this association have been limited to the biomechanical aspect reporting 
patients that have a loss of extension in their knee have decreased lumbar lordosis and 
this may affect their posture and result in pain.
55
  Based on the previous findings, chronic 
back pain can be used to identify a subgroup of people who may have reduced physical 
function after their TKA/THA.  Further research is required to evaluate if the impact of 
chronic back pain on TKA/THA recovery can be modified.   
 
5.5.3 Limitations 
Our study has several limitations.  This cohort was based from a single academic 
center orthopedic practice that may consist of patients with conditions that are more 
complicated than typically seen in the general total hip or knee arthroplasty population. 
Although when our study population’s preoperative lower-extremity physical function 
scores, BMI and age were compared with published total knee and hip arthroplasty 
studies, they were similar.
56-57
  
This study used physical function data gathered from routine clinical practice, 




of physical function.  The individuals not included in this study were similar in age and 
body mass index compared to the individuals in the study but information on physical 
function and comorbidity prevalence was unknown and may have biased the results.   
Although we accounted for known confounders, there may be unknown 
confounders that were not identified that could impact the relationship between MetS and 
physical function.  Specifically, we were unable to measure the amount and type of 
physical therapy the patient received after surgery and this may have influenced the level 
of physical function postoperatively.   
Due to the high reported prevalence of undiagnosed cardiometabolic risk factors, 
particularly the high rate of undiagnosed and/or untreated cardiometabolic risk in women, 
we may have underestimated the prevalence of MetS and the individual components.
58
   
Future research should incorporate current guidelines recommending a comprehensive 
assessment of cardiovascular
 
risk in both men and women.
59-61
  The evaluation should
 
include a complete a medical and family history to identify the presence
 
of a known 
history of cardiometabolic disease and a laboratory assessment (complete lipid panel and
 
fasting glucose level).   
 
5.6  Conclusion 
In our study, diabetes was the only CMR factor to be associated with worse 
postoperative physical function in the population with a TKA.  MetS was not associated 
with postoperative physical function in either the TKA or THA cohort.  Back pain and 
preoperative physical function were covariates that were found to significantly influence 




back pain and diabetes, modifiable conditions, may improve postoperative physical 
function.  Although it is well known that presurgical physical function impacts 
postoperative outcomes, further research is needed to understand how to improve 
presurgical physical function and if this improvement leads to improved postsurgical 
physical function.  Only two studies have investigated the association of cardiometabolic 
risk with physical function.  Future research is needed to reach a consensus whether these 
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DISCUSSION AND LIMITATIONS 
 
6.1  Overall study  
Due to the predicted increase hip and knee replacements in the next 20 years
1
 and 
the large (15-30%) proportion of those with TKA/THA who report lack of improvement 
in their pain, functional status, and overall health related quality of life
2-4
 evidence is 
warranted to provide guidance on the specific patient characteristics that affect 
TKA/THA outcomes.    
The overall purpose of this research topic was to identify patient characteristics 
and comorbidities that may influence the physical function of those undergoing 
TKA/THA surgery.  A greater number of comorbidities indicate worse postoperative 
outcomes.  The specificity of which comorbidity may be important to physical function is 
lacking.  The choice of CMR factors was based on the high prevalence of these 
conditions in the osteoarthritis (OA) population, the recent finding that MetS and OA 
may share similar etiology related to the inflammatory state and that CMR factors are 
modifiable.   
This research project provides a preliminary exploration into the effect that CMR 
factors, and comorbid conditions may have on physical function in the TKA/THA 




impacts postoperative outcomes.  A new finding from this study is that modifiable 
conditions, MetS, back pain, diabetes and insomnia, influence preoperative physical 
function.  This is important because treatment practice may alter preoperative physical 
function through the management of CMR factors and comorbid conditions, an area not 
yet addressed in the TKA/THA population. The possibility of changing postoperative 
outcomes through the mediation of preoperative physical function is an area in need of 
future research.  
 In the TKA population, diabetes was the only CMR factor to be associated with 
worse postoperative lower-extremity physical function recovery after adjusting for age, 
sex, and comorbid conditions.  There were no CMR factors associated with physical 
function in the THA population.  This may be a reflection of the differences between 
these two populations.  We found the prevalence of CMR factors in the THA population 
is much lower than the TKA population and those with a THA appeared to be a healthier 
population (13% THA had no risk factors vs 5% TKA).   
 There are limitations to this study.  First, the data used were from a real-world 
clinical practice setting and inclusive of diverse characteristics of those undergoing 
TKA/THA surgery.  The data are only as good as what is documented by the patient and 
in their patient record.  Although no differences were found between the patients included 
in the study and those that were not, there is still a chance that those that were not 
included in the study are different than the study sample.  Second, only one clinical 
practice, in an academic setting was used to evaluate the CMR factors in the TKA/THA 
population; therefore, the results may not be applicable to the general TKA/THA 




comorbidities, there may be unknown confounders that were not identified that could 
impact the relationship between MetS and physical function.  Fourth, it was not possible 
to achieve the study objective to evaluate the association of MetS with physical 
performance measures (PPM) in the TKA/THA population.  The implementation of the 
preoperative PPMs included only those patients that attended Joint Camp prior to their 
surgery.  Approximately 30% of the TKA/THA population attended Joint Camp 
preoperatively resulting in a severely limited the dataset that did not represent the study 
population.  Thus this subgroup was not analyzed in the final dissertation.  Finally, I had 
proposed tracking patients longitudinally over 6-12 months.  The verbal instructions from 
the orthopedic surgeon to the patient indicated a required follow-up visit would be 
scheduled postoperatively at 6 months or at 1 year (or both).  Although the orthopedic 
surgeon identified these follow-up appointments as an important part of the postoperative 
recovery condition, we found less than 50% of the patients returned for their 
postoperative visit.  Therefore, I did not include the 6-month time point in the analysis 
because of the severe loss of patient follow-up.   
 
6.2  HOAP project 
 The HOAP project was an immensely rewarding experience.  I was very fortunate 
to work with an incredible team of people that are dedicated to improving patient 
satisfaction and outcomes.  The HOAP project successfully adopted patient reported 
measures seamlessly into a very busy clinical practice.  The data collection process has 
continued for 2 ½ years and continues to function.  In the future, an evaluation of the 




from those undergoing surgery.    For example, one of the main goals of the HOAP 
project was to minimize the time required from patients to complete the measures.  To 
accomplish this we were required to the collect patient related outcomes prior to knowing 
who will go for surgery.  This provided the benefit of potentially evaluating those who 
and who do not undergo surgery but this process made tracking the surgical patient 
difficult.   
Presently the UOC is undergoing immense changes in the evaluation of outcomes.  
It would be my HOAP that our experience developing, implementing and analyzing this 
clinical data will provide a platform to discuss needs and wants for future outcomes 
research initiatives.   
 
6.3  Future research 
 In the evaluation of MetS with physical functional outcome, the future work 
should include preoperative measurements of the individual components of MetS that 
meet the standard definitions of MetS (i.e., serum cholesterol and triglyceride levels).  
This would allow systematic comparisons to be made in the TKA/THA population.    In 
addition, it would be interesting to take postoperative measurements to investigate 
whether MetS is changed because of the ability to mobilize is increased due to the 
TKA/THA surgery.  Second, future research is needed to ascertain if the trends we 
identified in this study continue over a longer duration in the recovery process. 
 In the management of patients with TKA/THA surgery, there is a need to 
preoperatively target a subgroup of people that have low preoperative physical function.  




model, which would include CMR factor education, treatment along with physical 
conditioning, on pre- and postoperative physical function.  Additionally we identified 
chronic back pain as an important contributor to worse physical function outcome post-
operatively.  Further research may include using specific chronic back pain measures to 
quantify and identify if back pain management strategies need to be incorporated into the 
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